[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 513
1. Zhong M, Wu L, Wang J, Zhang B, Hou L: [Expression of cyclin D1 and its inhibitors and hTERT in ameloblastoma]. Hua Xi Kou Qiang Yi Xue Za Zhi; 2006 Dec;24(6):495-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression of cyclin D1 and its inhibitors and hTERT in ameloblastoma].
  • OBJECTIVE: To investigate the expression of human telomerase reverse transcripase (hTERT), cyclin D1 mRNA, p16(INK4), p21(WAF1) mRNA and p27(KIP1) protein in human ameloblastoma (ABs).
  • [MeSH-minor] Ameloblastoma. Cyclin-Dependent Kinase Inhibitor p27. Cyclins. Humans. Immunohistochemistry. RNA, Messenger. Telomerase

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17334067.001).
  • [ISSN] 1000-1182
  • [Journal-full-title] Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology
  • [ISO-abbreviation] Hua Xi Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Cyclin-Dependent Kinase Inhibitor p21; 0 / Cyclins; 0 / RNA, Messenger; 136601-57-5 / Cyclin D1; 147604-94-2 / Cyclin-Dependent Kinase Inhibitor p27; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


2. Zhang L, Zeng D, Huang H, Wang J, Tao Q, Pan C, Xu J, Zhang B, Wang A: Tissue inhibitor of metalloproteinase-2 inhibits ameloblastoma growth in a new mouse xenograft disease model. J Oral Pathol Med; 2010 Jan;39(1):94-102
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tissue inhibitor of metalloproteinase-2 inhibits ameloblastoma growth in a new mouse xenograft disease model.
  • BACKGROUND: Ameloblastomas are odontogenic neoplasms characterized by local invasiveness.
  • This study was conducted to develop a new animal model of ameloblastoma and to address the role of tissue inhibitor of metalloproteinase-2 (TIMP-2) and matrix metalloproteinase-2 (MMP-2) in the growth and invasiveness of ameloblastomas.
  • METHOD: Donated fresh human ameloblastoma tissue was finely minced, screened, and subcutaneously implanted in three locations on each of 10 BALB/c-nu/nu nude mice.
  • RESULTS: The ameloblastoma xenografts were established with high frequency and contained a variety of typical features, validating this new model system.
  • CONCLUSIONS: We successfully established a new experimental model of ameloblastoma consisting of subcutaneous human xenografts in nude mice.
  • In addition, we demonstrated the successful introduction of the TIMP-2 gene in tumor xenograft cells in vivo, resulting in xenograft growth inhibition.
  • [MeSH-major] Ameloblastoma / drug therapy. Neoplasm Transplantation. Soft Tissue Neoplasms / drug therapy. Tissue Inhibitor of Metalloproteinase-2 / therapeutic use. Transplantation, Heterologous
  • [MeSH-minor] Adult. Animals. Blotting, Western. Disease Models, Animal. Female. Genetic Vectors / therapeutic use. Humans. Matrix Metalloproteinase 2. Matrix Metalloproteinase Inhibitors. Mice. Mice, Inbred BALB C. Mice, Nude. Neoplasm Invasiveness. Plasmids / therapeutic use. Reverse Transcriptase Polymerase Chain Reaction. Subcutaneous Tissue / surgery. Transfection. Tumor Cells, Cultured

  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19895658.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Matrix Metalloproteinase Inhibitors; 127497-59-0 / Tissue Inhibitor of Metalloproteinase-2; EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.24 / Mmp2 protein, mouse
  •  go-up   go-down


3. Koutlas IG, Koch CA, Vickers RA, Brouwers FM, Vortmeyer AO: An unusual ostensible example of intraoral basal cell carcinoma. J Cutan Pathol; 2009 Apr;36(4):464-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Tissue samples of the tumor were evaluated with monoclonal antibody Ber-EP4 and were compared with examples of oral mucosa, skin, oral and cutaneous squamous cell carcinoma, peripheral ameloblastoma, ameloblastoma and cutaneous basal cell carcinoma (BCC).
  • Examples of conventional ameloblastomas did not show evidence of LOH.
  • [MeSH-minor] Aged. Biomarkers, Tumor / metabolism. Female. Humans. Immunohistochemistry. Loss of Heterozygosity. Receptors, Cell Surface / genetics

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19278434.001).
  • [ISSN] 1600-0560
  • [Journal-full-title] Journal of cutaneous pathology
  • [ISO-abbreviation] J. Cutan. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Receptors, Cell Surface; 0 / human epithelial antigen-125; 0 / patched receptors
  •  go-up   go-down


Advertisement
4. Kumamoto H, Ooya K: Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas. J Oral Pathol Med; 2006 Mar;35(3):183-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunohistochemical detection of retinoblastoma protein and E2 promoter-binding factor-1 in ameloblastomas.
  • BACKGROUND: To clarify the roles of cell cycle regulation in oncogenesis and cytodifferentiation of odontogenic tumors, expression of retinoblastoma protein (RB) and E2 promoter-binding factor-1 (E2F-1) was analyzed in ameloblastomas as well as in tooth germs.
  • METHODS: Tissue specimens of 10 tooth germs, 40 benign ameloblastomas, and five malignant ameloblastomas were examined immunohistochemically with the use of antibodies against RB, E2F-1, and phosphorylated RB.
  • RESULTS: Immunohistochemical reactivity for RB, E2F-1, phosphorylated RB, and Ki-67 was detected in the nuclei of odontogenic epithelial cells near the basement membrane in tooth germs and benign and malignant ameloblastomas.
  • The levels of immunoreactivity for RB, E2F-1, phosphorylated RB, and Ki-67 were slightly higher in benign and malignant ameloblastomas than in tooth germs.
  • Plexiform ameloblastomas showed significantly higher expression of RB than follicular ameloblastomas.
  • Ki-67 immunoreactivity was significantly higher in ameloblastic carcinomas than in metastasizing ameloblastomas.
  • CONCLUSION: Similar immunoreactivity for RB, E2F-1, phosphorylated RB, and Ki-67 in tooth germs and ameloblastomas indicated cellular expression of phosphorylated RB and active-free E2F-1 in both normal and neoplastic odontogenic tissues.
  • [MeSH-major] Ameloblastoma / chemistry. E2F1 Transcription Factor / analysis. Retinoblastoma Protein / analysis

  • Genetic Alliance. consumer health - Retinoblastoma.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16454815.001).
  • [ISSN] 0904-2512
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / E2F1 Transcription Factor; 0 / Ki-67 Antigen; 0 / Retinoblastoma Protein
  •  go-up   go-down


5. Sathi GS, Han PP, Tamamura R, Nagatsuka H, Hu H, Katase N, Nagai N: Immunolocalization of cell signaling molecules in the granular cell ameloblastoma. J Oral Pathol Med; 2007 Nov;36(10):609-14
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunolocalization of cell signaling molecules in the granular cell ameloblastoma.
  • We attempted to localize these signaling molecules in the granular cell ameloblastoma.
  • MATERIALS AND METHODS: Four samples of paraffin-embedded ameloblastoma with granular cells were studied.
  • Immunoreactivities of basement membrane type HS, cell surface type HS, and heparanase were variable within granular cells in ameloblastoma.
  • CONCLUSION: Granular cells in ameloblastoma exhibit abnormal biological behaviors, particularly synthesis and secretion of protein.
  • [MeSH-major] Ameloblastoma / chemistry. Ameloblastoma / metabolism. Intercellular Signaling Peptides and Proteins / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17944754.001).
  • [ISSN] 0904-2512
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / BMP4 protein, human; 0 / Bone Morphogenetic Protein 4; 0 / Bone Morphogenetic Proteins; 0 / Intercellular Signaling Peptides and Proteins; 0 / Proto-Oncogene Proteins; 0 / WNT5A protein, human; 0 / Wnt Proteins; 0 / beta Catenin; 9050-30-0 / Heparitin Sulfate; EC 3.2.1.- / heparanase; EC 3.2.1.31 / Glucuronidase
  •  go-up   go-down


6. Bray D, Michael A, Falconer DT, Kaddour HS: Ameloblastoma: a rare nasal polyp. J Laryngol Otol; 2007 Jan;121(1):72-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma: a rare nasal polyp.
  • Ameloblastoma is an odontogenic neoplasm of enamel organ type tissue which does not undergo transformation to the point of enamel formation.
  • We present the second case in the English literature of maxillary ameloblastoma that presented with nasal obstruction and rhinorrhoea, and the first to be excised using a combined maxillotomy and endoscopic ethmoidectomy.
  • [MeSH-major] Ameloblastoma / pathology. Maxillary Neoplasms / pathology. Nasal Polyps / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17076931.001).
  • [ISSN] 1748-5460
  • [Journal-full-title] The Journal of laryngology and otology
  • [ISO-abbreviation] J Laryngol Otol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Number-of-references] 20
  •  go-up   go-down


7. Uçok O, Doğan N, Uçok C, Günhan O: Role of fine needle aspiration cytology in the preoperative presumptive diagnosis of ameloblastoma. Acta Cytol; 2005 Jan-Feb;49(1):38-42
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Role of fine needle aspiration cytology in the preoperative presumptive diagnosis of ameloblastoma.
  • OBJECTIVE: To determine the role of fine needle aspiration cytology (FNAC) on the preoperative presumptive diagnosis of ameloblastoma.
  • STUDY DESIGN: Sixty-three patients, diagnosed preoperatively and postoperatively with ameloblastoma, were evaluated between 1990 and 2003.
  • The patients were classified according to whether they were diagnosed with ameloblastoma preoperatively or postoperatively, on histologic examination.
  • RESULTS: The accuracy rate for ameloblastoma was 0.95% for all biopsy methods, while the incisional biopsy rate was 75.00%.
  • Concerning clinical diagnosis, ameloblastoma was mistaken mostly (56.41%) for odontogenic cysts (22 of 39).
  • [MeSH-major] Ameloblastoma / diagnosis. Mandibular Neoplasms / diagnosis. Maxillary Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15717753.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


8. Arotiba GT, Arotiba JT, Taiwo AO: Biologic, anatomic and clinical considerations in the management of the classic intraosseous ameloblastoma of the jaws. Nig Q J Hosp Med; 2010 Apr-Jun;20(2):55-63
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Biologic, anatomic and clinical considerations in the management of the classic intraosseous ameloblastoma of the jaws.
  • This paper reviews the types of surgical and nonsurgical treatment modalities that have been used to treat the classic intraosseous ameloblastoma of the jaws.
  • [MeSH-major] Ameloblastoma / surgery. Jaw Cysts / surgery. Jaw Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21243853.001).
  • [ISSN] 0189-2657
  • [Journal-full-title] Nigerian quarterly journal of hospital medicine
  • [ISO-abbreviation] Nig Q J Hosp Med
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Nigeria
  •  go-up   go-down


9. Gupta M, Motwani G, Gupta L: Ameloblastoma mandible: Repair by iliac crest graft following hemimandibulectomy. Indian J Otolaryngol Head Neck Surg; 2005 Oct;57(4):357-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma mandible: Repair by iliac crest graft following hemimandibulectomy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Oral Maxillofac Surg. 1997 Nov;55(11):1200-6 [9371107.001]
  • (PMID = 23120222.001).
  • [ISSN] 2231-3796
  • [Journal-full-title] Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India
  • [ISO-abbreviation] Indian J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC3451436
  •  go-up   go-down


10. Ndukwe KC, Adebiyi EK, Ugboko VI, Adeyemo WL, Ajayi FO, Ladeinde AL, Okojie VN, Ajike SO, Olasoji HO: Ameloblastic carcinoma: a multicenter Nigerian study. J Oral Maxillofac Surg; 2010 Sep;68(9):2111-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A majority of the cases (17) occurred de novo, and 3 patients presented with carcinoma ex-ameloblastoma.
  • [MeSH-major] Ameloblastoma / epidemiology. Carcinoma / epidemiology. Mandibular Neoplasms / epidemiology. Maxillary Neoplasms / epidemiology. Odontogenic Tumors / epidemiology

  • Genetic Alliance. consumer health - Ameloblastic carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20538397.001).
  • [ISSN] 1531-5053
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


11. Ide F, Obara K, Mishima K, Saito I: Ameloblastoma ex calcifying odontogenic cyst (dentinogenic ghost cell tumor). J Oral Pathol Med; 2005 Sep;34(8):511-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma ex calcifying odontogenic cyst (dentinogenic ghost cell tumor).
  • In this report, a rare case is described of ameloblastoma ex COC (dentinogenic ghost cell tumor) and the relevant literature is briefly reviewed.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology. Odontogenic Cyst, Calcifying / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16091120.001).
  • [ISSN] 0904-2512
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


12. Miyake T, Tanaka Y, Kato K, Tanaka M, Sato Y, Ijiri R, Inayama Y, Ito Y, Aoki S, Kawabe R, Tohnai I: Gene mutation analysis and immunohistochemical study of beta-catenin in odontogenic tumors. Pathol Int; 2006 Dec;56(12):732-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Six ameloblastomas (five follicular ameloblastomas and one plexiform ameloblastoma) and three malignant odontogenic tumors (one metastasizing ameloblastoma, one ameloblastic carcinoma, and one primary intraosseous odontogenic carcinoma) were investigated for CTNNB1 expression and CTNNB1 mutation.
  • Immunohistochemically, all follicular ameloblastomas and one primary intraosseous odontogenic carcinoma exhibited focal and moderate nuclear/cytoplasmic expression of CTNNB1, whereas the plexiform ameloblastoma and the remaining two malignant odontogenic tumors had entirely membranous expression.
  • CTNNB1 mutation at codon 40 of exon 3 was found in one of the six follicular ameloblastomas.
  • The other five follicular ameloblastomas, the plexiform ameloblastoma, and the three malignant odontogenic tumors did not show mutation in exon 3 of CTNNB1.
  • These findings further confirmed that CTNNB1 mutation is not frequent in ameloblastoma and malignant odontogenic tumors, although the abnormality of Wnt signaling may be associated with some of these tumors.
  • [MeSH-minor] Adolescent. Adult. Aged. Aged, 80 and over. Ameloblastoma / genetics. Ameloblastoma / pathology. Base Sequence. Child. DNA Mutational Analysis. Female. Humans. Immunohistochemistry. Male. Middle Aged. Molecular Sequence Data. Polymerase Chain Reaction

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17096730.001).
  • [ISSN] 1320-5463
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / beta Catenin
  •  go-up   go-down


13. Chandrasekar CR, Mohammed R, Rafalla AA, Grimer RJ: Adamantinoma of the calcaneum--a case report. Foot (Edinb); 2009 Mar;19(1):58-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma of the calcaneum--a case report.
  • Adamantinoma is rare, representing less than 1% of all primary malignant bone tumours.
  • Adamantinoma commonly occurs in the tibia.
  • Adamantinoma of the foot is extremely rare.
  • To our knowledge adamantinoma of the calcaneum has not been previously reported in the literature.
  • We report the case of a male patient, aged 33 years, who was treated for adamantinoma of the calcaneum and followed for 16 years highlighting the difficulty in diagnosis and management of this rare tumor occurring at a rare site.
  • [MeSH-major] Adamantinoma / pathology. Bone Neoplasms / pathology. Calcaneus / pathology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20307451.001).
  • [ISSN] 1532-2963
  • [Journal-full-title] Foot (Edinburgh, Scotland)
  • [ISO-abbreviation] Foot (Edinb)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


14. Van Rijn R, Bras J, Schaap G, van den Berg H, Maas M: Adamantinoma in childhood: report of six cases and review of the literature. Pediatr Radiol; 2006 Oct;36(10):1068-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma in childhood: report of six cases and review of the literature.
  • BACKGROUND: Adamantinoma is a rare slow-growing malignant bone tumour.
  • MATERIALS AND METHODS: The database of the Working Group on Paediatric Oncology, Academic Medical Centre/Emma Children's Hospital Amsterdam, was searched for cases of adamantinoma.
  • Additionally a literature study was performed to identify cases of adamantinoma in childhood.
  • RESULTS: We identified six local cases of adamantinoma of the long bones, two boys (age 3 and 8 years) and four girls (mean age 8.8 years, range 3.0-14.0 years).
  • On follow-up (mean 6.1 years, range 1.6-12.0 years) all children remained disease-free.
  • CONCLUSION: Although the incidence of adamantinoma is low, it is important to recognize this rare bone tumour, since in the early stages of the disease adequate treatment will result in an excellent prognosis.
  • [MeSH-major] Adamantinoma / diagnosis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Surg Pathol. 1981 Sep;5(6):533-42 [7325273.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1982;398(1):75-86 [6819703.001]
  • [Cites] Ann Pathol. 1993;13(5):336-40 [8311861.001]
  • [Cites] Rev Chir Orthop Reparatrice Appar Mot. 1995;81(4):333-7 [8560003.001]
  • [Cites] Acta Clin Belg. 1990;45(1):31-3 [2161603.001]
  • [Cites] Am J Roentgenol Radium Ther Nucl Med. 1966 Jul;97(3):727-32 [5927616.001]
  • [Cites] Pathol Res Pract. 1991 Dec;187(8):1039-43; discussion 1043-4 [1724319.001]
  • [Cites] Hum Genet. 1990 Oct;85(5):513-5 [2227936.001]
  • [Cites] Cancer. 1989 Dec 1;64(11):2319-34 [2804923.001]
  • [Cites] Acta Orthop Belg. 2002 Oct;68(4):412-6 [12415948.001]
  • [Cites] Clin Orthop Relat Res. 1989 Jan;(238):294-301 [2910613.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1975;365(1):63-74 [804740.001]
  • [Cites] Rofo. 1992 Sep;157(3):239-44 [1391818.001]
  • [Cites] Clin Orthop Relat Res. 1972 Jul-Aug;86:178-82 [5047786.001]
  • [Cites] Indian J Pathol Microbiol. 1980 Oct;23(4):293-8-B [7228218.001]
  • [Cites] Clin Orthop Relat Res. 1984 Nov;(190):299-310 [6207973.001]
  • [Cites] Cancer. 1989 Aug 1;64(3):730-7 [2743266.001]
  • [Cites] Cancer Genet Cytogenet. 1997 Aug;97(1):5-11 [9242211.001]
  • [Cites] Skeletal Radiol. 1988;17(7):522-6 [3201280.001]
  • [Cites] Clin Nucl Med. 2000 Dec;25(12 ):1057-8 [11129155.001]
  • [Cites] Vrach Delo. 1990 Jun;(6):96-8 [2399736.001]
  • [Cites] Int Orthop. 1994;18(6):379-88 [7698872.001]
  • [Cites] Pathologica. 1984 May-Jun;76(1043):313-22 [6493828.001]
  • [Cites] Arch Putti Chir Organi Mov. 1977;28:129-35 [931601.001]
  • [Cites] AJR Am J Roentgenol. 2004 Dec;183(6):1737-44 [15547221.001]
  • [Cites] J Belge Radiol. 1993 Jun;76(3):154-6 [8253651.001]
  • [Cites] Acta Cytol. 1988 Jul-Aug;32(4):579-81 [3041724.001]
  • [Cites] J Mol Diagn. 2001 Feb;3(1):16-21 [11227067.001]
  • [Cites] Johns Hopkins Med J. 1979 Sep;145(3):107-11 [381755.001]
  • [Cites] Unfallchirurgie. 1990 Feb;16(1):47-9 [2316056.001]
  • [Cites] Am J Clin Pathol. 1984 Oct;82(4):470-4 [6475846.001]
  • [Cites] Chest. 1991 Jul;100(1):279-81 [1647939.001]
  • [Cites] Int Orthop. 1986;10(4):253-9 [3804526.001]
  • [Cites] Acta Radiol. 1998 May;39(3):276-8 [9571943.001]
  • [Cites] J Bone Joint Surg Am. 1986 Jun;68(5):772-6 [3722237.001]
  • [Cites] Cancer Genet Cytogenet. 1989 Oct 15;42(2):187-90 [2790753.001]
  • [Cites] J Bone Joint Surg Am. 1987 Oct;69(8):1177-88 [3312206.001]
  • [Cites] Cancer. 1957 May-Jun;10(3):540-59 [13460949.001]
  • [Cites] Foot Ankle Int. 1997 Nov;18(11):746-51 [9391822.001]
  • [Cites] Cancer. 1985 Mar 1;55(5):1015-23 [2578304.001]
  • [Cites] Ugeskr Laeger. 1984 Aug 6;146(32):2401-3 [6515843.001]
  • [Cites] J Cancer Res Clin Oncol. 1982;104(3):315-20 [7161313.001]
  • [Cites] Histopathology. 1994 Jul;25(1):71-6 [7525449.001]
  • [Cites] Clin Orthop Relat Res. 1965 Nov-Dec;43:189-213 [5861090.001]
  • [Cites] Skeletal Radiol. 1992;21(8):493-502 [1281557.001]
  • [Cites] Chirurg. 1984 Jun;55(6):407-10 [6468037.001]
  • [Cites] Orthopedics. 1988 Nov;11(11):1565-6 [3200767.001]
  • [Cites] J Bone Joint Surg Am. 1994 Oct;76(10):1482-99 [7929496.001]
  • [Cites] Skeletal Radiol. 1990;19(1):55-8 [2326657.001]
  • [Cites] Skeletal Radiol. 1998 Jul;27(7):406-9 [9730336.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):215-37 [3514033.001]
  • (PMID = 16906392.001).
  • [ISSN] 0301-0449
  • [Journal-full-title] Pediatric radiology
  • [ISO-abbreviation] Pediatr Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  • [Number-of-references] 59
  •  go-up   go-down


15. Motamedi MH, Shafeie HA, Azizi T: Salvage of an impacted canine associated with an adenomatoid odontogenic tumour: a case report. Br Dent J; 2005 Jul 23;199(2):89-90
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The adenomatoid odontogenic tumour (AOT) has been known by a number of descriptive names (adenoameloblastoma, ameloblastic adenomatoid tumour, glandular ameloblastoma, and adenomatoid ameloblastoma) since it was first reported and later recognised as a distinct odontogenic lesion unrelated to ameloblastoma.
  • Although it was considered to be a variant of ameloblastoma at one time leading surgeons to perform unduly aggressive surgery, the treatment outcome experience has borne out the benign, nonaggressive nature of this lesion.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16041334.001).
  • [ISSN] 0007-0610
  • [Journal-full-title] British dental journal
  • [ISO-abbreviation] Br Dent J
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


16. Kamath KP, Vidya M, Shetty N, Karkera BV, Jogi H: Nucleolar organizing regions and alpha-smooth muscle actin expression in a case of ameloblastic carcinoma. Head Neck Pathol; 2010 Jun;4(2):157-62
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • It is defined as a malignant epithelial odontogenic tumor that histologically has retained the features of ameloblastic differentiation and also exhibits cytologic features of malignancy, like atypia and mitotic activity.
  • Although this lesion represents a separate entity, differentiating it from ameloblastoma has been often challenging to pathologists.
  • In this case study reporting a case of ameloblastic carcinoma, we have attempted to verify the previous findings on the use of Argyrophilic nucleolar organizing regions (AgNORs) and immunohistochemical staining for the alpha-smooth muscle actin (alpha-SMA) in differentiating ameloblastic carcinoma from ameloblastoma.
  • It was observed that AgNORs was found to be almost twice in ameloblastic carcinoma as it was in ameloblastoma.
  • A difference between the two lesions in the pattern of expression of alpha-SMA was also observed, with alpha-SMA being expressed in the odontogenic epithelium and the stroma of ameloblastic carcinoma whereas, in the case of ameloblastoma, it was found only in the stromal part.
  • These findings suggest that AgNORs and alpha-SMA expression may be used as adjuncts to the routine histopathologic examination to differentiate ameloblastic carcinoma and ameloblastoma.
  • [MeSH-major] Actins / metabolism. Ameloblastoma / pathology. Carcinoma / pathology. Mandibular Neoplasms / pathology. Nucleolus Organizer Region / pathology
  • [MeSH-minor] Antigens, Nuclear / analysis. Antigens, Nuclear / genetics. Biomarkers, Tumor / metabolism. Diagnosis, Differential. Humans. Immunohistochemistry. Male. Mandible / pathology. Mandible / surgery. Middle Aged

  • Genetic Alliance. consumer health - Ameloblastic carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Micron. 2000 Apr;31(2):117-20 [10588056.001]
  • [Cites] Oral Oncol. 2009 Sep;45(9):760-5 [19150605.001]
  • [Cites] J Oral Pathol Med. 2001 Sep;30(8):489-93 [11545240.001]
  • [Cites] Biol Chem. 2002 Jan;383(1):55-67 [11928823.001]
  • [Cites] J Pathol. 1987 Feb;151(2):111-8 [2437276.001]
  • [Cites] Lancet. 1987 Jun 20;1(8547):1413-4 [2438526.001]
  • [Cites] J Oral Pathol Med. 1996 Sep;25(8):436-40 [8930822.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998 Jan;85(1):78-81 [9474619.001]
  • [Cites] Pathol Res Pract. 1998;194(1):33-9 [9542745.001]
  • [Cites] Oral Oncol. 1999 Jan;35(1):70-6 [10211313.001]
  • [Cites] Wound Repair Regen. 2005 Jan-Feb;13(1):7-12 [15659031.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2005 Jul;289(1):G2-7 [15961883.001]
  • [Cites] Oral Oncol. 2005 Nov;41(10):1028-33 [16139563.001]
  • [Cites] Histopathology. 2007 Dec;51(6):849-53 [18042073.001]
  • [Cites] Indian J Dent Res. 2008 Apr-Jun;19(2):141-6 [18445932.001]
  • [Cites] Int J Cancer. 2008 Nov 15;123(10):2229-38 [18777559.001]
  • [Cites] Eur J Med Res. 2008 Oct 27;13(10):476-80 [19008176.001]
  • [Cites] Anticancer Res. 2008 Nov-Dec;28(6B):3847-54 [19192639.001]
  • [Cites] Pathol Int. 2009 Apr;59(4):229-33 [19351365.001]
  • [Cites] Head Neck Oncol. 2009;1:31 [19674470.001]
  • [Cites] Niger Postgrad Med J. 2001 Mar;8(1):7-11 [11487776.001]
  • (PMID = 20333560.001).
  • [ISSN] 1936-0568
  • [Journal-full-title] Head and neck pathology
  • [ISO-abbreviation] Head Neck Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / ACTA2 protein, human; 0 / Actins; 0 / Antigens, Nuclear; 0 / Biomarkers, Tumor; 0 / nucleolar organizer region associated proteins
  • [Other-IDs] NLM/ PMC2878627
  •  go-up   go-down


17. Papagelopoulos PJ, Savvidou OD, Mavrogenis AF, Galanis EC, Shaughnessy WJ, Unni KK, Sim FH: Lateral malleolus en bloc resection and ankle reconstruction for malignant tumors. Clin Orthop Relat Res; 2005 Aug;(437):209-18
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were four osteosarcomas, three chondrosarcomas, two Ewing's sarcomas, and one adamantinoma.
  • At the latest followup, all 10 patients showed no evidence of disease.
  • Five patients who had primary or late ankle arthrodesis had a Musculoskeletal Tumor Society and International Society of Limb Salvage functional score of 28 points (92%), and two adolescents who had postoperative bracing alone had a functional score of 24 points (80%).

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16056051.001).
  • [ISSN] 0009-921X
  • [Journal-full-title] Clinical orthopaedics and related research
  • [ISO-abbreviation] Clin. Orthop. Relat. Res.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


18. Vanoven BJ, Parker NP, Petruzzelli GJ: Peripheral ameloblastoma of the maxilla: a case report and literature review. Am J Otolaryngol; 2008 Sep-Oct;29(5):357-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral ameloblastoma of the maxilla: a case report and literature review.
  • Peripheral ameloblastoma is a rare, benign, extraosseous neoplasm of the odontogenic epithelium.
  • We report a case of peripheral ameloblastoma, detail our surgical therapy and review important elements in the pathological diagnosis and treatment of this unusual neoplasm.
  • [MeSH-major] Ameloblastoma / pathology. Ameloblastoma / surgery. Maxillary Neoplasms / pathology. Maxillary Neoplasms / surgery

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18722894.001).
  • [ISSN] 1532-818X
  • [Journal-full-title] American journal of otolaryngology
  • [ISO-abbreviation] Am J Otolaryngol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 23
  •  go-up   go-down


19. Tsujigiwa H, Nagatsuka H, Han PP, Gunduz M, Siar CH, Oida S, Nagai N: Analysis of amelogenin gene (AMGX, AMGY) expression in ameloblastoma. Oral Oncol; 2005 Sep;41(8):843-50
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of amelogenin gene (AMGX, AMGY) expression in ameloblastoma.
  • Although the amelogenin gene is expressed in ameloblastoma, the precise expression pattern of X and Y amelogenin genes (AMGX, AMGY) in this tumor has not yet been identified.
  • In this study, we analyzed amelogenin gene expression in 19 samples (9 male, 10 female) of oral ameloblastomas by RT-PCR and detect the chromosomal origin of amelogenin mRNA by restriction enzyme digestion of the RT-PCR product.
  • All tumor samples expressed amelogenin mRNA.
  • It is an interesting finding as in normal male tooth development, the expression of AMGY is very much lower than that of AMGX.
  • We postulate that epigenetic change of sex chromosomes may have some correlations with tumorigenesis of ameloblastoma.
  • [MeSH-major] Ameloblastoma / genetics. Dental Enamel Proteins / genetics. Jaw Neoplasms / genetics

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15979380.001).
  • [ISSN] 1368-8375
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Amelogenin; 0 / Dental Enamel Proteins
  •  go-up   go-down


20. Macanovic M, Gangidi S, Porter G, Brown S, Courtney D, Porter J: Incidental bony pathology when reporting trauma orthopantomograms. Clin Radiol; 2010 Oct;65(10):842-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this review we will present examples of the more common odontogenic lesions including: radicular cyst, odontogenic keratocyst, dentigerous cyst, ameloblastoma, and also examples of non-odontogenic pathology: bisphosphonate-related osteonecrosis of the jaw (BRONJ) and chronic osteomyelitis.

  • MedlinePlus Health Information. consumer health - Facial Injuries and Disorders.
  • MedlinePlus Health Information. consumer health - Osteonecrosis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20797471.001).
  • [ISSN] 1365-229X
  • [Journal-full-title] Clinical radiology
  • [ISO-abbreviation] Clin Radiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  •  go-up   go-down


21. Kuvat SV, Aydin A, Hafiz G, Aslan I, Hocaoğlu E, Biçer A, Yaprak B, Berköz O: [Reconstruction of the head and neck with free osteoseptocutaneous flap in elderly heavy smokers]. Kulak Burun Bogaz Ihtis Derg; 2008 Mar-Apr;18(2):61-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All cases but one with mandibular ameloblastoma had intraoral squamous cell carcinoma.
  • [MeSH-major] Ameloblastoma / surgery. Carcinoma, Squamous Cell / surgery. Head and Neck Neoplasms / surgery. Smoking / adverse effects. Surgical Flaps / adverse effects

  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • MedlinePlus Health Information. consumer health - Smoking.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18628637.001).
  • [ISSN] 1300-7475
  • [Journal-full-title] Kulak burun boğaz ihtisas dergisi : KBB = Journal of ear, nose, and throat
  • [ISO-abbreviation] Kulak Burun Bogaz Ihtis Derg
  • [Language] tur
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


22. Ahmed MM, El-Azab SM: Evaluation of cell cycle-related indicators in plexiform ameloblastoma. J Egypt Natl Canc Inst; 2008 Sep;20(3):294-301
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Evaluation of cell cycle-related indicators in plexiform ameloblastoma.
  • BACKGROUND: Ameloblastoma (AB) is a locally invasive neoplasm with a potentially destructive behavior.
  • PURPOSE: To determine whether cell cycle alteration plays a role in oncogenesis of plexiform ameloblastoma (PAB).
  • KEY WORDS: Plexiform ameloblastoma - p53 - p21 - Bcl2 - PCNA.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20424660.001).
  • [ISSN] 1110-0362
  • [Journal-full-title] Journal of the Egyptian National Cancer Institute
  • [ISO-abbreviation] J Egypt Natl Canc Inst
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Egypt
  •  go-up   go-down


23. Walker T, Chen T, Bergeron CM, Fischbein NJ, Kaplan MJ, Monfared A: Radiology quiz case 1. Ameloblastoma. Arch Otolaryngol Head Neck Surg; 2008 Mar;134(3):328, 330
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiology quiz case 1. Ameloblastoma.
  • [MeSH-major] Ameloblastoma / radiography. Mandibular Neoplasms / radiography

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18347263.001).
  • [ISSN] 0886-4470
  • [Journal-full-title] Archives of otolaryngology--head & neck surgery
  • [ISO-abbreviation] Arch. Otolaryngol. Head Neck Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


24. Ieni A, Barresi V, Grosso M, Rosa MA, Tuccari G: Lactoferrin immuno-expression in human normal and neoplastic bone tissue. J Bone Miner Metab; 2009;27(3):364-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Lactoferrin (Lf) expression was investigated by using a Lf monoclonal antibody in 50 formalin-fixed and paraffin-embedded human bone tumours [10 giant cell tumours (GCTs), 7 osteoid osteomas, 6 ossifying fibromas, 19 enchondromas, 2 chondroblastomas, 2 chondrosarcomas, 2 chondroblastic osteosarcomas, 1 myeloma and 1 adamantinoma] as well as in 8 samples of adult and foetal human normal bone specimens.
  • Lf immuno-expression with a variable ID score was encountered in 19/50 tumours and specifically in 10/10 GCTs, in 5/7 osteoid osteomas, in 2/2 chondroblastomas as well as in the adamantinoma and in the myeloma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer Res. 1995 Mar 1;55(5):1168-75 [7867003.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2198-203 [9122171.001]
  • [Cites] Oncol Rep. 2007 May;17(5):1021-6 [17390038.001]
  • [Cites] Bone Miner. 1992 Jan;16(1):37-48 [1531620.001]
  • [Cites] Histol Histopathol. 2002 Oct;17 (4):1077-83 [12371135.001]
  • [Cites] Blood. 1984 Nov;64(5):1103-9 [6593100.001]
  • [Cites] Oncol Rep. 2006 Aug;16(2):257-63 [16820900.001]
  • [Cites] Biometals. 2004 Jun;17(3):331-5 [15222486.001]
  • [Cites] J Pathol. 1999 Dec;189(4):463-9 [10629544.001]
  • [Cites] Eur J Histochem. 2005 Jan-Mar;49(1):33-8 [15823792.001]
  • [Cites] Cancer. 1985 Jun 1;55(11):2612-7 [3888366.001]
  • [Cites] Biochem Cell Biol. 2002;80(1):1-6 [11908632.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1984;403(1):59-66 [6202054.001]
  • [Cites] Haematologica. 1995 May-Jun;80(3):252-67 [7672721.001]
  • [Cites] Biochim Biophys Acta. 1998 Apr 24;1402(3):277-87 [9606986.001]
  • [Cites] Int J Cancer. 2005 Mar 20;114(2):299-306 [15543612.001]
  • [Cites] Mol Hum Reprod. 2002 Jan;8(1):58-67 [11756570.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1981;394(1-2):61-73 [6278702.001]
  • [Cites] Clin Cancer Res. 2004 Dec 15;10(24):8683-6 [15623653.001]
  • [Cites] Mol Hum Reprod. 2000 May;6(5):469-73 [10775652.001]
  • [Cites] J Bone Miner Res. 1996 Oct;11(10):1453-60 [8889845.001]
  • [Cites] Comp Biochem Physiol B. 1971 May 15;39(1):119-29 [4998849.001]
  • [Cites] Cell Mol Life Sci. 2005 Nov;62(22):2576-87 [16261253.001]
  • [Cites] J Cell Biochem. 1999 Sep 1;74(3):486-98 [10412049.001]
  • [Cites] J Clin Pathol. 1984 Jan;37(1):51-5 [6323544.001]
  • [Cites] J Clin Pathol. 1978 Apr;31(4):316-27 [346612.001]
  • [Cites] Histol Histopathol. 1992 Oct;7(4):543-7 [1457975.001]
  • [Cites] Exp Cell Res. 1999 Sep 15;251(2):257-63 [10471311.001]
  • [Cites] Eur J Histochem. 1999;43(4):317-22 [10682270.001]
  • [Cites] Arch Pathol Lab Med. 1989 Aug;113(8):912-5 [2757492.001]
  • [Cites] Clin Med Res. 2005 May;3(2):93-101 [16012127.001]
  • [Cites] J Cell Physiol. 1986 Jun;127(3):349-56 [2423539.001]
  • [Cites] Ann Pathol. 1992;12(6):347-52 [1294156.001]
  • [Cites] J Cell Physiol. 1992 Dec;153(3):477-82 [1447310.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1985;406(1):67-74 [3922110.001]
  • [Cites] Pathol Res Pract. 1987 Jun;182(3):344-51 [3628093.001]
  • [Cites] Eur J Biochem. 1989 Dec 8;186(1-2):367-73 [2557211.001]
  • [Cites] Immunol Today. 1995 Sep;16(9):417-9 [7546203.001]
  • [Cites] J Histochem Cytochem. 1983 Feb;31(2):336-44 [6300220.001]
  • [Cites] Hum Pathol. 2003 Oct;34(10):983-93 [14608531.001]
  • [Cites] Physiol Rev. 1984 Jan;64(1):65-102 [6420813.001]
  • [Cites] Science. 1999 Apr 2;284(5411):143-7 [10102814.001]
  • [Cites] Histol Histopathol. 1997 Jul;12(3):671-6 [9225149.001]
  • [Cites] Biochem Cell Biol. 2002;80(1):131-6 [11908637.001]
  • [Cites] Annu Rev Nutr. 1995;15:93-110 [8527233.001]
  • [Cites] Biotechnol Appl Biochem. 2001 Dec;34(Pt 3):151-9 [11730482.001]
  • (PMID = 19240970.001).
  • [ISSN] 0914-8779
  • [Journal-full-title] Journal of bone and mineral metabolism
  • [ISO-abbreviation] J. Bone Miner. Metab.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] EC 3.4.21.- / Lactoferrin
  •  go-up   go-down


25. Gleason BC, Liegl-Atzwanger B, Kozakewich HP, Connolly S, Gebhardt MC, Fletcher JA, Perez-Atayde AR: Osteofibrous dysplasia and adamantinoma in children and adolescents: a clinicopathologic reappraisal. Am J Surg Pathol; 2008 Mar;32(3):363-76
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Osteofibrous dysplasia and adamantinoma in children and adolescents: a clinicopathologic reappraisal.
  • Osteofibrous dysplasia (OFD) and adamantinoma are rare and most commonly arise in the tibia of young individuals.
  • Although OFD has typical histopathologic features, areas resembling OFD have often been noted at the periphery of otherwise classic adamantinomas, and some have suggested that OFD may be either a precursor to or a regressive phase of adamantinoma.
  • The so-called OFD-like adamantinoma encompasses some features of both OFD and adamantinoma.
  • Patients with OFD were generally younger than those with adamantinoma.
  • Osteoblastic and osteoclastic activity was more prominent in OFD than in OFD-like adamantinoma.
  • In addition to the inconspicuous small clusters of epithelial cells in OFD-like adamantinoma, isolated keratin-positive cells with a unique ultrastructural hybrid fibroblastic-epithelial phenotype were found in the stroma of all OFD and OFD-like adamantinomas.
  • Fluorescence in situ hybridization analysis revealed trisomies 7, 8, and/or 12 in the spindle cell stroma of OFD, OFD-like, and classic adamantinoma, supporting a neoplastic origin of OFD and a common histogenesis for all 3 lesions.
  • Of the 11 OFD patients with follow-up (median, 4.5 y), all 3 who underwent incisional biopsy had persistent, nonprogressive disease and 2 of 8 who underwent curettage or wide excision had recurrence; none developed adamantinoma.
  • All 6 adamantinoma patients with follow-up (3 classic and 3 OFD-like) were treated with wide excision.
  • One with classic adamantinoma died of pulmonary metastases 9 years after presentation; the other 5 were free of disease with a median follow-up of 12 years.
  • None of the classic adamantinomas evolved into OFD-like adamantinoma or OFD.
  • Although the histopathology, immunohistochemistry, ultrastructure, and cytogenetics indicate that these lesions are closely related, our data and the literature suggest that only classic adamantinoma has malignant potential.
  • OFD, OFD-like adamantinoma, and classic adamantinoma appear to show a progressive complexity of cytogenetic aberrations, perhaps indicative of a multistep neoplastic transformation.
  • [MeSH-major] Adamantinoma / pathology. Bone Neoplasms / pathology. Fibrous Dysplasia of Bone / pathology

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18300815.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


26. Gbolahan O, Fatusi O, Owotade F, Akinwande J, Adebiyi K: Clinicopathology of soft tissue lesions associated with extracted teeth. J Oral Maxillofac Surg; 2008 Nov;66(11):2284-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The noninflammatory lesions included dentigerous cyst (4%), central giant cell granuloma (1.3%), and ameloblastoma (0.7%).

  • MedlinePlus Health Information. consumer health - Jaw Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18940493.001).
  • [ISSN] 1531-5053
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


27. Okada H, Yamamoto H, Tilakaratne WM: Odontogenic tumors in Sri Lanka: analysis of 226 cases. J Oral Maxillofac Surg; 2007 May;65(5):875-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: The most prevalent tumor was ameloblastoma (69.8%); odontoma was the fourth most prevalent (4.5%).
  • CONCLUSIONS: The comparative data with statistically significant differences suggest a geographical difference in the relative prevalence of ameloblastoma among various continents.
  • It is suggested that ameloblastoma most frequently occurs in the mandible (the posterior region) in all Asian, African, and South American countries.

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17448836.001).
  • [ISSN] 0278-2391
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


28. Sathi GA, Inoue M, Harada H, Rodriguez AP, Tamamura R, Tsujigiwa H, Borkosky SS, Gunduz M, Nagatsuka H: Secreted frizzled related protein (sFRP)-2 inhibits bone formation and promotes cell proliferation in ameloblastoma. Oral Oncol; 2009 Oct;45(10):856-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Secreted frizzled related protein (sFRP)-2 inhibits bone formation and promotes cell proliferation in ameloblastoma.
  • Secreted frizzled related protein (sFRP)-2, a Wnt antagonist, was strongly expressed by both stromal and tumor cells of ameloblastoma.
  • The aim of this study is to evaluate whether sFRP-2 secreted from tumor cells have any direct role in suppressed bone formation or not.
  • A pre-osteoblastic cell line, KUSA/A1 cells, cultured in conditioned medium of an ameloblastoma-derived cell line (AM-1CM) was used in the study.
  • KUSA/A1 cells cultured in AM-1CM showed high cell proliferation, low ALP activity without mineralized matrix deposition. sFRP-2 was strongly expressed in ameloblastoma tissue and AM-1 cells.
  • In this study, it was confirmed that ameloblastoma cells have a major role in decreased bone formation by secreting sFRP-2 in cell culture model.
  • Though, sFRP-2 has great effect on tumor progression, inhibition of sFRP-2's anti-bone formation activity and cell proliferative activity may reduce the invasive property of ameloblastoma and possibility of recurrence rate.
  • [MeSH-major] Ameloblastoma / metabolism. Cell Proliferation. Jaw Neoplasms / metabolism. Membrane Proteins / physiology. Neoplasm Proteins / physiology. Osteogenesis / physiology
  • [MeSH-minor] Alkaline Phosphatase / metabolism. Calcification, Physiologic / drug effects. Calcification, Physiologic / physiology. Cell Line, Tumor. Enzyme Induction. Humans. Osteoblasts / physiology. Wnt Proteins / antagonists & inhibitors

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19362047.001).
  • [ISSN] 1879-0593
  • [Journal-full-title] Oral oncology
  • [ISO-abbreviation] Oral Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Membrane Proteins; 0 / Neoplasm Proteins; 0 / SFRP2 protein, human; 0 / Wnt Proteins; EC 3.1.3.1 / Alkaline Phosphatase
  •  go-up   go-down


29. Hirota M, Aoki S, Kawabe R, Fujita K: Desmoplastic ameloblastoma featuring basal cell ameloblastoma: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2005 Feb;99(2):160-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Desmoplastic ameloblastoma featuring basal cell ameloblastoma: a case report.
  • The desmoplastic ameloblastoma is a histological variant of ameloblastoma.
  • The neoplastic epithelial islands seen in desmoplastic ameloblastoma are small and ameloblastic cells are rare.
  • Basal cell ameloblastoma is also a rare variant of ameloblastoma, in which the tumor is composed of more primitive cells and has even fewer features of peripheral palisading.
  • This report describes the case of a 17-year-old female with an ameloblastoma in the right anterior maxilla.
  • A partial maxillectomy for tumor resection was performed under general anesthesia.
  • Histologically, ameloblastic tumor cells were seen with dense collagenous stroma and the tumor cells showed primarily basal cell variants of ameloblastoma.
  • [MeSH-major] Ameloblastoma / pathology. Maxillary Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15660085.001).
  • [ISSN] 1079-2104
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 9007-34-5 / Collagen
  • [Number-of-references] 24
  •  go-up   go-down


30. Tawfik MA, Zyada MM: Odontogenic tumors in Dakahlia, Egypt: analysis of 82 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Feb;109(2):e67-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ameloblastoma (41.5%) was the most frequent type, followed by keratocystic odontogenic tumor (19.5%), odontoma (13.4%), and odontogenic myxoma (8.5%).
  • In Dakahlia, Egypt, ameloblastoma and keratocystic odontogenic tumor are the most frequent odontogenic tumors, with distinct anatomic predilections.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 Mosby, Inc. All rights reserved.
  • (PMID = 19969486.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Fujii H, Honoki K, Enomoto Y, Kasai T, Kido A, Amano I, Kumamoto M, Morishita T, Mii Y, Nonomura A, Takakura Y: Adamantinoma-like Ewing's sarcoma with EWS-FLI1 fusion gene: a case report. Virchows Arch; 2006 Nov;449(5):579-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Adamantinoma-like Ewing's sarcoma with EWS-FLI1 fusion gene: a case report.
  • Recent studies have advocated the genotypic and phenotypic delineation of a novel Ewing's sarcoma histologic variant showing epithelial features defined as "adamantinoma-like Ewing's sarcoma".
  • The diagnosis of the lesion was confirmed as Ewing's sarcoma by the presence of the EWS-FLI1 fusion transcript, and could be defined as the so-called "adamantinoma-like Ewing's sarcoma".
  • [MeSH-major] Adamantinoma / pathology. Bone Neoplasms / pathology. Oncogene Proteins, Fusion / genetics. Proto-Oncogene Protein c-fli-1 / genetics. Sarcoma, Ewing / pathology

  • Genetic Alliance. consumer health - Ewing's Sarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Pathol Res Pract. 1979 Dec;166(1):112-22 [551397.001]
  • [Cites] C R Seances Acad Sci III. 1983;296(23):1105-7 [6416623.001]
  • [Cites] Am J Surg Pathol. 1981 Sep;5(6):533-42 [7325273.001]
  • [Cites] Med Pediatr Oncol. 2003 May;40(5):276-87 [12652615.001]
  • [Cites] Am J Surg Pathol. 2005 Aug;29(8):1025-33 [16006796.001]
  • [Cites] CA Cancer J Clin. 1972 Mar-Apr;22(2):95-8 [4622125.001]
  • [Cites] Am J Surg Pathol. 1993 Dec;17(12):1225-33 [7694513.001]
  • [Cites] Genes Chromosomes Cancer. 1992 Nov;5(4):271-7 [1283315.001]
  • [Cites] Skeletal Radiol. 1994 Oct;23(7):501-7 [7824975.001]
  • [Cites] Cancer Genet Cytogenet. 1984 May;12(1):1-19 [6713356.001]
  • [Cites] Skeletal Radiol. 1992;21(3):205-9 [1604351.001]
  • [Cites] Cancer. 1992 Feb 1;69(3):698-708 [1730120.001]
  • [Cites] J Clin Oncol. 1993 Oct;11(10):1911-8 [8410118.001]
  • [Cites] Am J Surg Pathol. 2003 Dec;27(12):1530-7 [14657712.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1975;365(1):63-74 [804740.001]
  • [Cites] J Clin Oncol. 1993 Aug;11(8):1482-8 [8101562.001]
  • [Cites] Skeletal Radiol. 1983;10 (1):61-6 [6879221.001]
  • [Cites] Am J Surg Pathol. 2000 Mar;24(3):410-6 [10716155.001]
  • [Cites] J Pathol. 2001 Sep;195(2):218-21 [11592101.001]
  • [Cites] Am J Surg Pathol. 1999 Feb;23 (2):159-65 [9989842.001]
  • [Cites] Cancer Res. 2005 Dec 15;65(24):11459-68 [16357154.001]
  • [Cites] Am J Pathol. 1991 Aug;139(2):317-25 [1867320.001]
  • [Cites] Clin Orthop Relat Res. 1993 Jan;(286):241-6 [8425352.001]
  • [Cites] J Clin Oncol. 2003 Aug 15;21(16):3072-8 [12915596.001]
  • [Cites] Am J Pathol. 1987 May;127(2):288-304 [2437802.001]
  • [Cites] J Bone Joint Surg Am. 1994 Oct;76(10):1482-99 [7929496.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):215-37 [3514033.001]
  • (PMID = 17016721.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / EWS-FLI fusion protein; 0 / Oncogene Proteins, Fusion; 0 / Proto-Oncogene Protein c-fli-1; 0 / RNA-Binding Protein EWS
  •  go-up   go-down


32. Kitkumthorn N, Mutirangura A: LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor. Oral Dis; 2010 Apr;16(3):286-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] LINE-1 methylation difference between ameloblastoma and keratocystic odontogenic tumor.
  • Keratocystic odontogenic tumor (KCOT) and ameloblastoma are different tumors but posses the same tissue in origin.
  • Here, we investigated long interspersed nuclear element-1 (LINE-1 or L1) methylation status between ameloblastoma and KCOT.
  • MATERIALS AND METHODS: We studied the methylation levels of the long interspersed nucleotide element-1 (LINE-1) in ameloblastoma and KCOT.
  • After collecting ameloblastoma cells and epithelium lining cells of KCOT by laser capture microdissection from paraffin embedded tissue, combined bisulfite restriction analysis of LINE-1 (COBRALINE-1) was performed to measure LINE-1 methylation levels.
  • RESULTS: The LINE-1 methylation level in KCOT (53.16 +/- 12.03%) was higher than that in ameloblastoma (36.90 +/- 16.52%), with a statistical significance of P = 0.001.
  • CONCLUSION: We found LINE-1 hypomethylation levels between ameloblastoma and KCOT are different.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Ameloblastoma / chemistry. Ameloblastoma / genetics. Child. DNA Methylation. Female. Humans. Keratins. Male. Middle Aged. Promoter Regions, Genetic. Restriction Mapping / methods. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20374511.001).
  • [ISSN] 1601-0825
  • [Journal-full-title] Oral diseases
  • [ISO-abbreviation] Oral Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 68238-35-7 / Keratins
  •  go-up   go-down


33. Sumi M, Ichikawa Y, Katayama I, Tashiro S, Nakamura T: Diffusion-weighted MR imaging of ameloblastomas and keratocystic odontogenic tumors: differentiation by apparent diffusion coefficients of cystic lesions. AJNR Am J Neuroradiol; 2008 Nov;29(10):1897-901
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Diffusion-weighted MR imaging of ameloblastomas and keratocystic odontogenic tumors: differentiation by apparent diffusion coefficients of cystic lesions.
  • BACKGROUND AND PURPOSE: Ameloblastomas and keratocystic odontogenic tumors are major aggressive odontogenic tumors in the maxillomandibular regions, but the differentiation between these 2 tumors is frequently ineffective based on only conventional CT and MR imaging findings.
  • MATERIALS AND METHODS: We prospectively studied 9 patients with ameloblastoma and 7 patients with keratocystic odontogenic tumor using diffusion-weighted MR imaging.
  • The type A nonenhancing lesions were observed in all the ameloblastomas, but they were evident in only 2 keratocystic odontogenic tumors.
  • It is interesting to note that the ADCs of the nonenhancing lesions in the ameloblastomas were significantly higher than those of the nonenhancing lesions in the keratocystic odontogenic tumors (2.48 +/- 0.20 x 10(-3) mm(2)/s vs 1.13 +/- 0.56 x 10(-3) mm(2)/s; P < .001).
  • The ADCs of the solid lesions in the ameloblastomas (1.39 +/- 0.15 x 10(-3) mm(2)/s) were significantly lower than those of the nonenhancing lesions in the ameloblastomas and were similar to those of the nonenhancing lesions in the keratocystic odontogenic tumors.
  • CONCLUSION: ADC determination may be used as an adjunct tool for differentiation between ameloblastomas and keratocystic odontogenic tumors.
  • [MeSH-major] Ameloblastoma / diagnosis. Diffusion Magnetic Resonance Imaging / methods. Image Interpretation, Computer-Assisted / methods. Mandibular Neoplasms / diagnosis. Odontogenic Cysts / diagnosis. Odontogenic Tumors / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18719033.001).
  • [ISSN] 1936-959X
  • [Journal-full-title] AJNR. American journal of neuroradiology
  • [ISO-abbreviation] AJNR Am J Neuroradiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Zhang B, Zhang J, Huang HZ, Chen WL, Tao Q, Zeng DL, Zhang LT, Xu JH: Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity. J Oral Pathol Med; 2009 Oct;38(9):731-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inhibition of ameloblastoma invasion in vitro and in vivo by inhibitor of metalloproteinase-2 activity.
  • BACKGROUND: Ameloblastoma is an odontogenic benign tumor characterized by local invasiveness and most of its local recurrences clinically result from local invasion.
  • This study used matrix metalloproteinase-2 (MMP-2) inhibitor I (MMP-2I) to investigate the role played by MMP-2 activity in the local invasiveness of ameloblastoma.
  • METHODS: The cells and xenografts of ameloblastoma were treated with MMP-2I and treatment group were compared with the control group.
  • In vitro, the invasive activity of tumor cells was assayed in transwell cell culture chamber.
  • In vivo, bilateral subrenal capsule xenograft transplantation of ameloblastoma was performed in 10 nude mice and the invasion of ameloblastoma into the renal parenchyma was observed.
  • Accordingly, potential of in vitro cell invasion, adhesion and in vivo tumor invasion were also significantly lower in the treatment group than in the control group.
  • CONCLUSIONS: Inhibitor of MMP-2 activity suppressed the local invasive capability of ameloblastoma by decreasing MMP-2 activity.
  • MMP-2 activity is in relation with invasive capacity of ameloblastoma.
  • [MeSH-major] Ameloblastoma / enzymology. Jaw Neoplasms / enzymology. Matrix Metalloproteinase Inhibitors. Tissue Inhibitor of Metalloproteinase-2 / pharmacology
  • [MeSH-minor] Animals. Humans. Matrix Metalloproteinase 2 / physiology. Mice. Mice, Inbred BALB C. Mice, Nude. Neoplasm Invasiveness. Neoplasm Transplantation. Tumor Cells, Cultured

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19473446.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Matrix Metalloproteinase Inhibitors; 127497-59-0 / Tissue Inhibitor of Metalloproteinase-2; EC 3.4.24.24 / Matrix Metalloproteinase 2
  •  go-up   go-down


35. Sakurai T: [Osseointegrated implant treatment to the region of tumor extirpation in a patient with ameloblastoma]. Nihon Hotetsu Shika Gakkai Zasshi; 2007 Jul;51(3):596-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Osseointegrated implant treatment to the region of tumor extirpation in a patient with ameloblastoma].
  • PATIENT: A 22 year-old female patient with defects of left mandibular molars and alveolar bone due to ameloblastoma visited our hospital with the chief complaint of occlusal instability and masticatory dysfunction.
  • Four years have passed since the tumor extirpation, and no signs of recurrence have been found.
  • CONCLUSION: It is suggested that prosthetic treatment using osseointegrated implant in the region of tumor extirpation is one of the most effective treatments for recovery of the stomatognathic system.
  • [MeSH-major] Ameloblastoma / surgery. Dental Implantation, Endosseous. Mandibular Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17957842.001).
  • [ISSN] 0389-5386
  • [Journal-full-title] Nihon Hotetsu Shika Gakkai zasshi
  • [ISO-abbreviation] Nihon Hotetsu Shika Gakkai Zasshi
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


36. Mareque Bueno J, Mareque Bueno S, Pamias Romero J, Bescos Atín MS, Huguet Redecilla P, Raspall Martín G: Mandibular ameloblastoma. Reconstruction with iliac crest graft and implants. Med Oral Patol Oral Cir Bucal; 2007 Jan;12(1):E73-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mandibular ameloblastoma. Reconstruction with iliac crest graft and implants.
  • The ameloblastoma is a bening odontogenic tumor.
  • [MeSH-major] Ameloblastoma / surgery. Bone Plates. Ilium / transplantation. Mandibular Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17195835.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 11
  •  go-up   go-down


37. Nikitakis NG, Brooks JK: Hard swelling in the right mandible. Ameloblastoma. Gen Dent; 2008 Mar-Apr;56(2):214, 217
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hard swelling in the right mandible. Ameloblastoma.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18348384.001).
  • [ISSN] 0363-6771
  • [Journal-full-title] General dentistry
  • [ISO-abbreviation] Gen Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


38. Weber K, Damron TA, Frassica FJ, Sim FH: Malignant bone tumors. Instr Course Lect; 2008;57:673-88
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Rare tumors such as chordoma and adamantinoma have anatomic predilections for the sacrum and tibia, respectively.
  • The primary symptom of a patient with a malignant bone tumor is pain, which often occurs at rest or at night.
  • Patients with a likely malignancy require thorough staging to determine the extent of disease and a well-planned biopsy for accurate diagnosis.
  • Knowledge of specific tumor characteristics and treatment options for osteosarcoma, Ewing's sarcoma, chondrosarcoma, malignant fibrous histiocytoma, chordoma, and adamantinoma is important.

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18399615.001).
  • [ISSN] 0065-6895
  • [Journal-full-title] Instructional course lectures
  • [ISO-abbreviation] Instr Course Lect
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Number-of-references] 42
  •  go-up   go-down


39. Häring P, Filippi A, Bornstein MM, Altermatt HJ, Buser D, Lambrecht JT: [The "globulomaxillary cyst" a specific entity or a myth?]. Schweiz Monatsschr Zahnmed; 2006;116(4):380-97
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Therefore, globulomaxillary cysts have to be diagnosed alternatively after a thorough clinical, radiological and histological examination as other odontogenic cysts like dentigerous cysts or odontogenic keratocysts, odontogenic tumors like ameloblastoma, central giant cell tumors, solitary bone cysts, etc.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16708524.001).
  • [ISSN] 0256-2855
  • [Journal-full-title] Schweizer Monatsschrift fur Zahnmedizin = Revue mensuelle suisse d'odonto-stomatologie = Rivista mensile svizzera di odontologia e stomatologia
  • [ISO-abbreviation] Schweiz Monatsschr Zahnmed
  • [Language] FRE; GER
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 81
  •  go-up   go-down


40. Martins WD: A case of recurrent ameloblastoma developing in an autogenous iliac bone graft. Dentomaxillofac Radiol; 2006 Sep;35(5):390; author reply 390
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of recurrent ameloblastoma developing in an autogenous iliac bone graft.
  • [MeSH-major] Ameloblastoma / pathology. Bone Transplantation / pathology. Mandibular Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Bone Grafts.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Dentomaxillofac Radiol. 2006 Jan;35(1):43-6 [16421264.001]
  • (PMID = 16940492.001).
  • [ISSN] 0250-832X
  • [Journal-full-title] Dento maxillo facial radiology
  • [ISO-abbreviation] Dentomaxillofac Radiol
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] England
  •  go-up   go-down


41. Gomes CC, Duarte AP, Diniz MG, Gomez RS: Review article: Current concepts of ameloblastoma pathogenesis. J Oral Pathol Med; 2010 Sep;39(8):585-91
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Review article: Current concepts of ameloblastoma pathogenesis.
  • Ameloblastoma is a locally destructive and invasive tumour that can recur despite adequate surgical removal.
  • Molecular studies have offered interesting findings regarding ameloblastoma pathogenesis.
  • It is clear from the literature reviewed that translational studies are necessary to identify prognostic markers of ameloblastoma behaviour and to establish new diagnostic tools to the differential diagnosis of unicystic from multicystic ameloblastoma.
  • [MeSH-major] Ameloblastoma / etiology
  • [MeSH-minor] Apoptosis / genetics. Cell Proliferation. Clone Cells. Dental Enamel Proteins / genetics. Genes, Tumor Suppressor / physiology. Humans. Matrix Metalloproteinases / physiology. Osteoclasts / physiology. Signal Transduction / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2010 John Wiley & Sons A/S.
  • (PMID = 20618608.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / AMBN protein, human; 0 / Dental Enamel Proteins; EC 3.4.24.- / Matrix Metalloproteinases
  •  go-up   go-down


42. Ghandhi D, Ayoub AF, Pogrel MA, MacDonald G, Brocklebank LM, Moos KF: Ameloblastoma: a surgeon's dilemma. J Oral Maxillofac Surg; 2006 Jul;64(7):1010-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma: a surgeon's dilemma.
  • PURPOSE: To investigate whether there were any significant differences in the mode of presentation, treatment, and outcome of patients presenting with a primary diagnosis of ameloblastoma in Glasgow, Scotland and San Francisco, CA.
  • MATERIALS AND METHODS: All cases of ameloblastoma seen in both institutions between January 1, 1980 and December 31, 1999 were included in this study.
  • Primary care by conservative treatment led to a recurrence in approximately 80% of cases and this included cases of unicystic ameloblastoma.
  • CONCLUSION: The mode of presentation, diagnosis, and management of the ameloblastoma was remarkably similar in Glasgow and San Francisco.
  • The recurrence rate following local enucleation and curettage was unacceptably high, and this included the cases of unicystic ameloblastoma, which should be treated more aggressively than has been recommended in the past.
  • [MeSH-major] Ameloblastoma / epidemiology. Mandibular Neoplasms. Maxillary Neoplasms. Neoplasm Recurrence, Local

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16781332.001).
  • [ISSN] 0278-2391
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Multicenter Study
  • [Publication-country] United States
  •  go-up   go-down


43. Niu CH, Li TJ: [Mutation and polymorphism of the ameloblastin gene in ameloblastomas]. Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Nov;41(11):678-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Mutation and polymorphism of the ameloblastin gene in ameloblastomas].
  • OBJECTIVE: To investigate the presence of mutation or polymorphism of ameloblastin (AMBN) gene in ameloblastomas.
  • METHODS: Genomic DNA was extracted from frozen tissues of 10 ameloblastomas and one malignant ameloblastoma.
  • Restriction fragment length polymorphism (RFLP) analysis was used to further determine the nature of the changes in AMBN detected in tumor samples in comparison to 100 control samples.
  • RESULTS: AMBN mutation was not identified in all 11 tumor samples.
  • CONCLUSIONS: AMBN gene mutation is not identified in the present group of ameloblastomas.
  • The frequently detected AMBN alterations in ameloblastomas are polymorphisms, which appear to be unrelated to the occurrence of ameloblastomas.
  • [MeSH-major] Ameloblastoma / genetics. Dental Enamel Proteins / genetics. Jaw Neoplasms / genetics. Polymorphism, Genetic

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17331365.001).
  • [ISSN] 1002-0098
  • [Journal-full-title] Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
  • [ISO-abbreviation] Zhonghua Kou Qiang Yi Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / AMBN protein, human; 0 / Dental Enamel Proteins
  •  go-up   go-down


44. Naik V, Kale AD: Ameloblastic carcinoma: a case report. Quintessence Int; 2007 Nov-Dec;38(10):873-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Ameloblastic carcinoma is a rare malignant lesion with characteristic histologic features and behavior that dictate a more radical surgical approach than does a simple ameloblastoma.
  • Clinically, ameloblastic carcinoma is more aggressive than most typical ameloblastomas with extensive local destruction, perforation of the cortical plate, extension into surrounding soft tissues, numerous recurrent lesions, and metastasis, usually to cervical lymph nodes.
  • The radiographic appearance of ameloblastic carcinoma is consistent with that of ameloblastoma except for occasional presence of some focal radiopacities, apparently reflecting dystrophic calcification.
  • Histologically, the tumor cells resemble cells seen in ameloblastoma but show cytologic atypia, cellular pleomorphism, nuclear hyperchromatism, mitoses, and vascular and neural invasion.
  • It is probable that ameloblastoma, like other tumors (such as carcinoid tumors and epithelial tumors of the ovary), shows a spectrum of histologic and biologic behavior ranging from benignity at one end to frank malignancy at the other.

  • Genetic Alliance. consumer health - Ameloblastic carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18197328.001).
  • [ISSN] 1936-7163
  • [Journal-full-title] Quintessence international (Berlin, Germany : 1985)
  • [ISO-abbreviation] Quintessence Int
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


45. Carnelio S, Vij H: Expression of tenascin and nucleolar organizer region in ameloblastoma and ameloblastic fibroma. J Oral Pathol Med; 2010 Mar;39(3):223-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of tenascin and nucleolar organizer region in ameloblastoma and ameloblastic fibroma.
  • BACKGROUND: The aim of this study was to assess the expression, distribution and comparison of tenascin, a glycoprotein of the extracellular matrix in ameloblastoma and ameloblastic fibroma, both odontogenic neoplasms with diverse biological behavior and to understand the proliferative activity by using the morphometric analysis.
  • METHODS: Paraffin embedded tissue from 25 cases of odontogenic tumors i.e., ameloblastoma (n = 15) and ameloblastic fibroma (n = 10) were used.
  • Morphometric analysis of nucleolar organizer regions (NORs) from ameloblastoma and ameloblastic fibroma was carried out by silver staining.
  • RESULTS: A heterogeneous expression of tenascin was found in ameloblastoma which was mainly localized at the epithelial-mesenchymal interface and a patchy distribution was observed in the stroma (80%), while strong positivity was observed in the stroma and at the basement membrane zone of ameloblastic fibroma (100%).
  • argyrophilic nucleolar organizer regions (AgNORs) revealed higher mean counts in ameloblastoma (3.093 +/- 0.902) when compared with those of ameloblastic fibroma (1.553 +/- 0.250).
  • Ameloblastoma presented more than two NORs (two to five) per nucleus in majority of the cells, while ameloblastic fibroma exhibited only one NORs per nucleus.
  • CONCLUSIONS: Expression of tenascin in these neoplasms suggest that it could play a role in epithelial- mesenchymal interaction, while AgNORs reveal that ameloblastomas are more aggressive when compared with ameloblastic fibromas.
  • [MeSH-major] Ameloblastoma / pathology. Nucleolus Organizer Region / ultrastructure. Odontogenic Tumors / pathology. Tenascin / analysis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19943856.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Tenascin
  •  go-up   go-down


46. Lee JW, Fang JJ, Chang LR, Yu CK: Mandibular defect reconstruction with the help of mirror imaging coupled with laser stereolithographic modeling technique. J Formos Med Assoc; 2007 Mar;106(3):244-50
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This case report describes a large ameloblastoma at the left lower molar region and ascending ramus of the mandible in a 53-year-old male patient.
  • The tumor mass together with the left mandible from the second premolar to the condylar head area was resected en bloc.

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17389170.001).
  • [ISSN] 0929-6646
  • [Journal-full-title] Journal of the Formosan Medical Association = Taiwan yi zhi
  • [ISO-abbreviation] J. Formos. Med. Assoc.
  • [Language] ENG
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Singapore
  •  go-up   go-down


47. Pogrel MA, Montes DM: Is there a role for enucleation in the management of ameloblastoma? Int J Oral Maxillofac Surg; 2009 Aug;38(8):807-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Is there a role for enucleation in the management of ameloblastoma?
  • This study aimed to determine the appropriate long-term management for ameloblastoma and the role of enucleation in the management of the subtypes of ameloblastoma (solid ameloblastomas, cystic ameloblastomas and peripheral ameloblastomas).
  • Solid and multicystic ameloblastomas have a high recurrence rate (60-80%) with simple enucleation and require more aggressive treatment.
  • For the unicystic ameloblastoma recurrence rates are high for simple enucleation.
  • The intraluminal subtype of unicystic ameloblastoma may do well with enucleation, but the intramural subtype may not, and since these cannot be identified preoperatively more aggressive treatment is recommended, including peripheral ostectomy or enucleation with subsequent treatment of the surrounding bone with liquid nitrogen, Carnoy's solution, or similar physicochemical modality.
  • The peripheral ameloblastoma has a different origin and responds to local excision.
  • [MeSH-major] Ameloblastoma / surgery. Jaw Neoplasms / surgery

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. ETHANOL .
  • Hazardous Substances Data Bank. ACETIC ACID .
  • Hazardous Substances Data Bank. CHLOROFORM .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19297131.001).
  • [ISSN] 1399-0020
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Carnoy's solution; 3K9958V90M / Ethanol; 7V31YC746X / Chloroform; Q40Q9N063P / Acetic Acid
  • [Number-of-references] 60
  •  go-up   go-down


48. Zhang LL, Yang R, Zhang L, Li W, MacDonald-Jankowski D, Poh CF: Dentigerous cyst: a retrospective clinicopathological analysis of 2082 dentigerous cysts in British Columbia, Canada. Int J Oral Maxillofac Surg; 2010 Sep;39(9):878-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • DCs can co-exist with other more serious conditions, such as odontogenic keratocyst or cystic ameloblastoma.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20605411.001).
  • [ISSN] 1399-0020
  • [Journal-full-title] International journal of oral and maxillofacial surgery
  • [ISO-abbreviation] Int J Oral Maxillofac Surg
  • [Language] eng
  • [Grant] Canada / Canadian Institutes of Health Research / /
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  •  go-up   go-down


49. Pitak-Arnnop P, Chaine A, Dhanuthai K, Bertrand JC, Bertolus C: Unicystic ameloblastoma of the maxillary sinus: Pitfalls of diagnosis and management. Hippokratia; 2010 Jul;14(3):217-20
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unicystic ameloblastoma of the maxillary sinus: Pitfalls of diagnosis and management.
  • BACKGROUND: Ameloblastoma is a common odontogenic tumor of the jaws that comprises 3 variants: conventional (solid), unicystic and peripheral ameloblastomas.
  • Unicystic ameloblastoma (UA) in the maxillary sinus is very rare.
  • RESULTS: The patient was successfully treated by enucleation of the tumor and curettage.
  • It is therefore of great benefit to organize continuing education for general physicians who initially meet oral disease patients as a 'gate keeper'.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20981175.001).
  • [ISSN] 1790-8019
  • [Journal-full-title] Hippokratia
  • [ISO-abbreviation] Hippokratia
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Greece
  • [Other-IDs] NLM/ PMC2943364
  • [Keywords] NOTNLM ; jaw tumor / maxillary sinus / orofacial infection / unicystic ameloblastoma
  •  go-up   go-down


50. Brkić A, Mutlu S, Koçak-Berberoğlu H, Olgaç V: Pathological changes and immunoexpression of p63 gene in dental follicles of asymptomatic impacted lower third molars: an immunohistochemical study. J Craniofac Surg; 2010 May;21(3):854-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Histopathologic examinations of the specimens revealed 47 normal dental follicular tissues, 1 ameloblastoma, and 2 dentigerous cysts. p63 Immunoexpressivity was stronger in the DFs of the group with completely impacted teeth (64%),than it was in the case of DFs of the group with partially impacted teeth (40%).
  • [MeSH-minor] Adolescent. Adult. Ameloblastoma / metabolism. Ameloblastoma / pathology. Dentigerous Cyst / metabolism. Dentigerous Cyst / pathology. Female. Humans. Immunoenzyme Techniques. Jaw Neoplasms / metabolism. Jaw Neoplasms / pathology. Jaw Neoplasms / radiography. Male

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20485068.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CKAP4 protein, human; 0 / Membrane Proteins
  •  go-up   go-down


51. Ide F, Mishima K, Yamada H, Horie N, Saito I, Shimoyama T, Kusama K: Unsuspected small ameloblastoma in the alveolar bone: a collaborative study of 14 cases with discussion of their cellular sources. J Oral Pathol Med; 2008 Apr;37(4):221-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Unsuspected small ameloblastoma in the alveolar bone: a collaborative study of 14 cases with discussion of their cellular sources.
  • BACKGROUND: Intraosseous ameloblastoma (IA) is the quintessence of epithelial odontogenic tumor and histologically and behaviorally defined as an undoubted neoplastic process.
  • RESULTS: Six cases were a chance finding.
  • The main location of tumor was microscopically traceable in six cases; three interradicular type outside the periodontal ligament space and two periradicular and one periapical variants inside.
  • CONCLUSION: By in-depth evaluation of the spatial relationship between tumor and its surrounding structure, the alveolar process, periodontal ligament space, and pericoronal area are all the likely starting points of IA.
  • [MeSH-major] Alveolar Process / pathology. Ameloblastoma / pathology. Jaw Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18221325.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Denmark
  • [Number-of-references] 48
  •  go-up   go-down


52. Kruse AL, Zwahlen RA, Grätz KW: New classification of maxillary ameloblastic carcinoma based on an evidence-based literature review over the last 60 years. Head Neck Oncol; 2009;1:31
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The ameloblastic carcinoma is a rare malignant odontogenic tumor which rather occurs in the mandible than in the maxilla.
  • Nineteen of 26 patients (73,1%) were controlled during a median follow-up time of 54,3 months (6 to 156 months); 6 patients died of disease after a median time of 62,7 months (7 to 156 months) after initial diagnosis.
  • CONCLUSION: It is of utmost importance to be aware of that ameloblastomas may be capable to degenerate into a "malignant" disease with recurrence and metastasis.
  • [MeSH-major] Ameloblastoma / classification. Maxillary Neoplasms / classification

  • Genetic Alliance. consumer health - Ameloblastic carcinoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Oral Maxillofac Surg. 1993 Oct;51(10):1152-5; discussion 1156-7 [8410456.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1993 Jul;29B(3):169-71 [8298419.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1995 Mar;31B(2):86-99 [7633291.001]
  • [Cites] J Laryngol Otol. 1995 Oct;109(10):1019-22 [7499939.001]
  • [Cites] Diagn Cytopathol. 1996 May;14(3):249-52 [8732656.001]
  • [Cites] J Oral Pathol Med. 1998 Jan;27(1):39-42 [9466734.001]
  • [Cites] J Craniomaxillofac Surg. 1998 Jun;26(3):159-62 [9702634.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1999 Aug;88(2):170-6 [10468461.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Apr;65(4):777-83 [17368379.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Jun;103(6):799-807 [17448710.001]
  • [Cites] J Oral Maxillofac Surg. 2007 Sep;65(9):1800-3 [17719401.001]
  • [Cites] Ann Surg. 1948 Nov;128(5):999-1005 [17859260.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007 Dec;104(6):e17-24 [17942338.001]
  • [Cites] Pediatr Blood Cancer. 2008 Jan;50(1):175-6 [16652346.001]
  • [Cites] Pathologe. 2008 May;29(3):214-20 [18330573.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):649-53 [11402276.001]
  • [Cites] J Oral Maxillofac Surg. 2002 Jan;60(1):102-4 [11757019.001]
  • [Cites] J Craniomaxillofac Surg. 2002 Oct;30(5):273-9 [12377199.001]
  • [Cites] J Oral Maxillofac Surg. 2003 Jun;61(6):731-4 [12796889.001]
  • [Cites] Oral Oncol. 2003 Oct;39(7):736-41 [12907214.001]
  • [Cites] J Can Dent Assoc. 2003 Oct;69(9):573-6 [14653932.001]
  • [Cites] J Craniofac Surg. 2004 Mar;15(2):264-9 [15167247.001]
  • [Cites] Laryngoscope. 2004 Oct;114(10):1770-4 [15454770.001]
  • [Cites] Bull Tokyo Dent Coll. 1972 May;13(2):91-101 [4504978.001]
  • [Cites] Virchows Arch A Pathol Anat Histol. 1979 Feb 9;381(2):211-22 [154765.001]
  • [Cites] J Oral Surg. 1980 Mar;38(3):203-6 [6928185.001]
  • [Cites] Am J Clin Pathol. 1981 Apr;75(4):585-91 [7223720.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1982 Sep;54(3):299-303 [6957827.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1983 Sep-Oct;92(5 Pt 1):532 [6625456.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1984 Feb;57(2):168-76 [6366686.001]
  • [Cites] J Oral Med. 1986 Apr-Jun;41(2):79-81 [3459830.001]
  • [Cites] J Maxillofac Surg. 1986 Dec;14(6):338-40 [3467002.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1987 Nov;64(5):570-6 [3313152.001]
  • [Cites] Am J Clin Pathol. 1988 Oct;90(4):474-81 [3052019.001]
  • [Cites] J Otolaryngol. 1989 Apr;18(3):109-11 [2716084.001]
  • [Cites] J Craniomaxillofac Surg. 1990 Aug;18(6):247-50 [2212021.001]
  • (PMID = 19674470.001).
  • [ISSN] 1758-3284
  • [Journal-full-title] Head & neck oncology
  • [ISO-abbreviation] Head Neck Oncol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC2733136
  • [General-notes] NLM/ Original DateCompleted: 20100629
  •  go-up   go-down


53. Ide F, Mishima K, Miyazaki Y, Saito I, Kusama K: Peripheral ameloblastoma in-situ: an evidential fact of surface epithelium origin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov;108(5):763-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral ameloblastoma in-situ: an evidential fact of surface epithelium origin.
  • The proposed origin from the adult gingival epithelium for peripheral ameloblastoma is difficult to prove and still remains unresolved.
  • In addition to the morphologic overlap, early ameloblastoma epithelia shared antigenic properties with tumor cells of representative control examples of peripheral ameloblastoma.
  • This is the first description of an in situ lesion of peripheral ameloblastoma, to our knowledge, and its multifocal ameloblastoma changes can be accepted as a direct proof of origin from the surface epithelium.
  • [MeSH-major] Ameloblastoma / pathology. Gingival Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 May;109(5):655-6; author reply 656-7 [20416531.001]
  • (PMID = 19748296.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, Neoplasm
  •  go-up   go-down


54. Arotiba GT, Ladeinde AL, Arotiba JT, Ajike SO, Ugboko VI, Ajayi OF: Ameloblastoma in Nigerian children and adolescents: a review of 79 cases. J Oral Maxillofac Surg; 2005 Jun;63(6):747-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma in Nigerian children and adolescents: a review of 79 cases.
  • PURPOSE: To descriptively review the clinicopathologic presentation and management of ameloblastoma in Nigerian children and adolescents and compare this with previous reports in the literature.
  • RESULTS: Out of a total of 360 patients with a diagnosis of ameloblastoma, 79 were under 20 years of age at presentation (21.9%).
  • The most common morphologic type was solid multicystic ameloblastoma (82.3%).
  • In most patients (57.3%), the symphysial region of the mandible was involved by the tumor.
  • CONCLUSION: Ameloblastoma in Nigerian children and adolescents exhibit some peculiar clinical features: these include the predominance of males, and of the solid multicystic morphologic type.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15944968.001).
  • [ISSN] 0278-2391
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


55. Oliveira J, Dorado L, Albota G, Sawatary Y, Koch DB: Prosthetic rehabilitation post resection of maxillary ameloblastoma: a case report. Dent Implantol Update; 2008 Dec;19(12):89-95
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Prosthetic rehabilitation post resection of maxillary ameloblastoma: a case report.
  • [MeSH-major] Ameloblastoma / rehabilitation. Dental Prosthesis Retention / instrumentation. Jaw, Edentulous, Partially / rehabilitation. Maxillary Neoplasms / rehabilitation. Palatal Obturators

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19238776.001).
  • [ISSN] 1062-0346
  • [Journal-full-title] Dental implantology update
  • [ISO-abbreviation] Dent Implantol Update
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Toida M, Balázs M, Treszl A, Rákosy Z, Kato K, Yamazaki Y, Matsui T, Suwa T, Hatakeyama D, Makita H, Mori S, Yamashita T, Shibata T, Adány R: Analysis of ameloblastomas by comparative genomic hybridization and fluorescence in situ hybridization. Cancer Genet Cytogenet; 2005 Jun;159(2):99-104
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Analysis of ameloblastomas by comparative genomic hybridization and fluorescence in situ hybridization.
  • In order to characterize the chromosomal alterations in ameloblastomas, a combination of comparative genomic hybridization (CGH) and fluorescence in situ hybridization (FISH) techniques was performed on 9 tumors.
  • Chromosomal alterations including a gain at 1q and losses at 1pter, 10q, and 22q could be detected by CGH only in 1 tumor.
  • Interphase FISH analysis, using centromeric probes for chromosomes 1, 10, and 22 as well as region-specific probes for 1p36 and 10q26, revealed the most frequent alterations to exist in the tumor with the abnormal CGH profile.
  • Moreover, FISH analysis revealed a frequent loss of chromosome 22 in all tumors examined, except for one lesion, indicating that loss of the entire or a part of this chromosome is a common event in ameloblastomas, possibly being a predisposing factor to ameloblastoma tumorigenesis.
  • [MeSH-minor] Adolescent. Adult. Aged. Ameloblastoma. Chromosomes, Human, Pair 1. Chromosomes, Human, Pair 10. Chromosomes, Human, Pair 22. Female. Gene Dosage. Humans. In Situ Hybridization, Fluorescence. Male. Middle Aged. Nucleic Acid Hybridization

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15899380.001).
  • [ISSN] 0165-4608
  • [Journal-full-title] Cancer genetics and cytogenetics
  • [ISO-abbreviation] Cancer Genet. Cytogenet.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


57. DeVilliers P, Liu H, Suggs C, Simmons D, Daly B, Zhang S, Raubenheimer E, Larsson A, Wright T: Calretinin expression in the differential diagnosis of human ameloblastoma and keratocystic odontogenic tumor. Am J Surg Pathol; 2008 Feb;32(2):256-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Calretinin expression in the differential diagnosis of human ameloblastoma and keratocystic odontogenic tumor.
  • Ameloblastoma is a benign, locally aggressive epithelial odontogenic tumor that has the potential to become malignant and produce metastasis to distant sites such as lungs and kidneys.
  • The histologic presentation can be, in some instances, mistaken for keratocystic odontogenic tumor (KCOT) (formerly known as odontogenic keratocyst).
  • The expression of calretinin [calbindin2 (CALB2)] was investigated on both ameloblastoma and KCOT.
  • Nineteen cases of ameloblastoma and 17 cases of KCOT were stained with calretinin antiserum 18-0211 (Zymed, San Francisco, CA).
  • All cases (100%) of ameloblastoma showed positive calretinin staining, restricted to the neoplastic epithelial component and none (0%) of the 17 KCOTs showed positive calretinin staining.
  • Gene expression profiling of ameloblastomas showed CALB2 expressed in the basal cell layer of columnar cells resembling preameloblasts, in all 5 of the ameloblastomas evaluated.
  • Taken together, the results of this study strongly support calretinin as a useful immunohistochemical marker for ameloblastoma and malignant ameloblastoma and it can also be used in the differential diagnosis of KCOT.
  • [MeSH-major] Ameloblastoma / diagnosis. Biomarkers, Tumor / metabolism. Jaw Neoplasms / diagnosis. Odontogenic Cysts / diagnosis. Odontogenic Tumors / diagnosis. S100 Calcium Binding Protein G / metabolism

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18223328.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Grant] United States / NIDCR NIH HHS / DE / DE016079
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CALB2 protein, human; 0 / Calbindin 2; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / S100 Calcium Binding Protein G
  •  go-up   go-down


58. Borucinska JD, Schmidt B, Tolisano J, Woodward D: Molecular markers of cancer in cartilaginous fish: immunocytochemical study of PCNA, p-53, myc and ras expression in neoplastic and hyperplastic tissues from free ranging blue sharks, Prionace glauca (L.). J Fish Dis; 2008 Feb;31(2):107-15
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The lesions examined in this study included two well differentiated adenomatous gastric polyps, a testicular capsular mesothelioma, a gingival fibropapilloma with elements of ameloblastoma, three liver tumours, two pericardial fibropapillomas and six cases of proliferative serositis (pericarditis and peritonitis).
  • [MeSH-minor] Animals. Antibodies / analysis. Antibodies / metabolism. Male. Proliferating Cell Nuclear Antigen / analysis. Proliferating Cell Nuclear Antigen / biosynthesis. Proliferating Cell Nuclear Antigen / immunology. Proto-Oncogene Proteins c-myc / analysis. Proto-Oncogene Proteins c-myc / biosynthesis. Tumor Suppressor Protein p53 / analysis. Tumor Suppressor Protein p53 / biosynthesis. ras Proteins / analysis. ras Proteins / biosynthesis

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18234018.001).
  • [ISSN] 0140-7775
  • [Journal-full-title] Journal of fish diseases
  • [ISO-abbreviation] J. Fish Dis.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibodies; 0 / Biomarkers; 0 / Proliferating Cell Nuclear Antigen; 0 / Proto-Oncogene Proteins c-myc; 0 / Tumor Suppressor Protein p53; EC 3.6.5.2 / ras Proteins
  •  go-up   go-down


59. Siar CH, Nakano K, Han PP, Nagatsuka H, Ng KH, Kawakami T: Differential expression of Notch receptors and their ligands in desmoplastic ameloblastoma. J Oral Pathol Med; 2010 Aug 1;39(7):552-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Differential expression of Notch receptors and their ligands in desmoplastic ameloblastoma.
  • The ameloblastoma, a benign odontogenic epithelial neoplasm, histologically recapitulates the enamel organ at bell stage.
  • Notch has been detected in the plexiform and follicular ameloblastoma.
  • Its activity in the desmoplastic ameloblastoma is unknown.
  • METHOD: Notch1-4 and their ligands (Jagged1, Jagged2 and Delta1) were examined immunohistochemically in 10 cases of desmoplastic ameloblastoma.
  • RESULTS: Ameloblastoma tumor epithelium demonstrated positive expression for Notch1 (n = 5/10), Notch3 (n = 8/10), Notch4 (n = 10/10), Jagged1 (n = 6/10) and Delta1 (n = 5/10), but no reactivity for Notch2 (n = 10/10) and Jagged2 (10/10).
  • CONCLUSIONS: These findings suggest that Notch receptors and their ligands may play differing roles during the development of the desmoplastic ameloblastoma with Notch4 probably playing a greater role in the acquisition of tissue-specific cellular characteristics in the desmoplastic ameloblastoma.
  • [MeSH-major] Ameloblastoma / pathology. Receptors, Notch / analysis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20337864.001).
  • [ISSN] 1600-0714
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Calcium-Binding Proteins; 0 / Intercellular Signaling Peptides and Proteins; 0 / Intracellular Signaling Peptides and Proteins; 0 / JAG2 protein, human; 0 / Ligands; 0 / Membrane Proteins; 0 / NOTCH1 protein, human; 0 / NOTCH2 protein, human; 0 / NOTCH3 protein, human; 0 / NOTCH4 protein, human; 0 / Proto-Oncogene Proteins; 0 / Receptor, Notch1; 0 / Receptor, Notch2; 0 / Receptors, Notch; 0 / delta protein; 134324-36-0 / Serrate proteins
  •  go-up   go-down


60. Alaeddini M, Etemad-Moghadam S, Baghaii F: Comparative expression of calretinin in selected odontogenic tumours: a possible relationship to histogenesis. Histopathology; 2008 Feb;52(3):299-304
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS AND RESULTS: Immunohistochemistry for calretinin was performed on 55 odontogenic tumours consisting of 20 solid ameloblastomas, five calcifying epithelial odontogenic tumours, 10 adenomatoid odontogenic tumours, 10 ameloblastic fibromas and 10 odontogenic myxomas.
  • All 20 ameloblastomas showed intense immunopositivity with a diffuse distribution pattern.
  • CONCLUSIONS: Considering that ameloblastomas, in contrast to the other studied tumours, were consistently reactive for calretinin, this protein may have a role in the pathogenesis of this aggressive neoplasm.
  • [MeSH-major] Ameloblastoma / metabolism. Biomarkers, Tumor / metabolism. Jaw Neoplasms / metabolism. Odontogenic Tumor, Squamous / metabolism. S100 Calcium Binding Protein G / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18269580.001).
  • [ISSN] 1365-2559
  • [Journal-full-title] Histopathology
  • [ISO-abbreviation] Histopathology
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / CALB2 protein, human; 0 / Calbindin 2; 0 / S100 Calcium Binding Protein G
  •  go-up   go-down


61. Hayes MI, Prince SE: Peripheral ameloblastoma: a case report. Dent Update; 2006 Dec;33(10):624-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral ameloblastoma: a case report.
  • Peripheral ameloblastoma is an uncommon pathological variant of the more usual intraosseous central ameloblastoma.
  • There was no evidence of bony involvement on radiographs but it was revealed histologically to be a peripheral ameloblastoma.
  • [MeSH-major] Ameloblastoma / diagnosis. Gingival Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17209538.001).
  • [ISSN] 0305-5000
  • [Journal-full-title] Dental update
  • [ISO-abbreviation] Dent Update
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


62. Yuan XP, Xie BK, Lin XF, Liang BL, Zhang F, Li JT: [Value of multi-slice spiral CT with three-dimensional reconstruction in the diagnosis of neoplastic lesions in the jawbones]. Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug;28(9):1700-2, 1706
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of these patients, 14 had ameloblastoma, 8 had hemangioma, 3 had osteosarcoma, 3 had ossifying fibroma, 2 had chondrosarcoma, 2 had fibrosarcoma, and 1 had odontogenic myxoma.
  • CONCLUSION: MSCT examination is useful in defining the scope of tumor involvement and bony changes to help in the definite diagnosis, differential diagnosis and choice of clinical treatment.
  • Two-dimensional imaging, MPR, VRT and CRP have their respective advantages and limitations in showing jawbone tumor, and their combination can be of great clinical value.
  • [MeSH-minor] Adolescent. Adult. Ameloblastoma / diagnosis. Female. Hemangioma / diagnosis. Humans. Male. Middle Aged. Reproducibility of Results. Sensitivity and Specificity. Young Adult

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18819902.001).
  • [ISSN] 1673-4254
  • [Journal-full-title] Nan fang yi ke da xue xue bao = Journal of Southern Medical University
  • [ISO-abbreviation] Nan Fang Yi Ke Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


63. Namba Y, Kimata Y, Koshima I, Sugihara S, Sato T: Fibular osteoadiposal flap for treatment of tibial adamantinoma: a case report. Acta Med Okayama; 2006 Aug;60(4):233-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Fibular osteoadiposal flap for treatment of tibial adamantinoma: a case report.
  • We treated a case with left tibial adamantinoma by use of a contralateral fibular osteoadiposal flap.
  • [MeSH-major] Adamantinoma / surgery. Bone Neoplasms / surgery. Fibula / surgery. Skin Transplantation. Surgical Flaps. Tibia / surgery

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16943861.001).
  • [ISSN] 0386-300X
  • [Journal-full-title] Acta medica Okayama
  • [ISO-abbreviation] Acta Med. Okayama
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


64. Chuang FH, Wang WC, Shen YH, Lin LM, Chen YK: Occurrence of ameloblastoma in a patient with nasopharyngeal carcinoma after treatment by irradiation. Spec Care Dentist; 2010 Jan-Feb;30(1):27-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Occurrence of ameloblastoma in a patient with nasopharyngeal carcinoma after treatment by irradiation.
  • Ameloblastoma is the most common clinically significant epithelial odontogenic tumor, and is considered a benign but locally aggressive tumor of the craniofacial region.
  • We present the case history of a 46-year-old male patient who had a nasopharyngeal carcinoma (NPC) treated by irradiation, which was complicated by the occurrence of an ameloblastoma.
  • Following a review of the English language literature, this case history was identified as being the first report, to our knowledge, of the occurrence of ameloblastoma in a patient who had been irradiated for an NPC.
  • [MeSH-major] Ameloblastoma / diagnosis. Carcinoma / radiotherapy. Mandibular Neoplasms / diagnosis. Nasopharyngeal Neoplasms / radiotherapy. Neoplasms, Second Primary / diagnosis

  • Genetic Alliance. consumer health - Nasopharyngeal carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20051072.001).
  • [ISSN] 1754-4505
  • [Journal-full-title] Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry
  • [ISO-abbreviation] Spec Care Dentist
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 12
  •  go-up   go-down


65. Folpe AL, Goldblum JR, Rubin BP, Shehata BM, Liu W, Dei Tos AP, Weiss SW: Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol; 2005 Aug;29(8):1025-33
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases.
  • More than 85% of Ewing sarcoma/primitive neuroectodermal tumor (ES/PNET), or "Ewing family of tumors" (EFTs), have the translocation, t (11;22) (q24;q12), with others having variant translocations.
  • We therefore studied a large group of genetically confirmed EFTs to more completely understand the morphologic and immunophenotypic spectrum of this rare sarcoma.
  • Histologically, 46 cases (73%) showed only typical features of ES, 9 cases (16%) showed features of PNET, 3 cases (5%) showed "adamantinoma-like" features, 3 cases (5%) corresponded to "atypical Ewing sarcoma," 3 cases (5%) showed principally intersecting fascicles of spindled cells, and 2 cases had abundant hyalinized matrix.
  • HMWCK was expressed only in "adamantinoma-like" EFTs, none of which expressed DES.
  • In conclusion, most, but not all, EFTs can be accurately diagnosed using time-honored morphologic criteria and ancillary immunohistochemistry.
  • However, genetic confirmation remains essential for the diagnosis of unusual morphologic variants of EFT, including "adamantinoma-like," spindled, sclerosing, and clear cell/anaplastic variants.
  • Therefore, to exclude or confirm the diagnosis of Ewing's sarcoma in round cell sarcomas having a variety of patterns but not specifically conforming to a tumor of known lineage (eg, rhabdomyosarcoma), cytogenetics, and/or molecular analysis is required.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16006796.001).
  • [ISSN] 0147-5185
  • [Journal-full-title] The American journal of surgical pathology
  • [ISO-abbreviation] Am. J. Surg. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / CD99 protein, human; 0 / Cell Adhesion Molecules; 0 / Desmin; 0 / FLII protein, human; 0 / Gelsolin; 0 / Microfilament Proteins; 0 / Receptors, Cytoplasmic and Nuclear; 68238-35-7 / Keratins; EC 2.7.10.1 / Proto-Oncogene Proteins c-kit
  •  go-up   go-down


66. Mendenhall WM, Werning JW, Fernandes R, Malyapa RS, Mendenhall NP: Ameloblastoma. Am J Clin Oncol; 2007 Dec;30(6):645-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Ameloblastoma.
  • The purpose of this article is to review the pertinent literature and discuss the optimal treatment and outcomes for patients with ameloblastoma.
  • Ameloblastoma is an uncommon benign, locally aggressive odontogenic neoplasm that usually occurs in the vicinity of the mandibular molars or ramus.
  • Uncontrolled, ameloblastoma may cause significant morbidity and occasionally death.
  • The majority of ameloblastomas are multicystic, which are more difficult to eradicate than the unicystic and peripheral varieties.
  • In contrast, conservative procedures such as enucleation and/or curettage result in local control rates of approximately 80% and 50% for unicystic and multicystic ameloblastomas, respectively.
  • Limited experience with radiotherapy indicates that it may reduce the risk of progression and result in long-term local control in the occasional patient with incompletely resectable disease.
  • The optimal treatment for ameloblastoma is wide en bloc resection.
  • Radiotherapy may improve the likelihood of local control in the occasional patient with incompletely resectable tumor.
  • [MeSH-major] Ameloblastoma / radiotherapy. Ameloblastoma / surgery. Jaw Neoplasms / radiotherapy. Jaw Neoplasms / surgery

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18091060.001).
  • [ISSN] 1537-453X
  • [Journal-full-title] American journal of clinical oncology
  • [ISO-abbreviation] Am. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 27
  •  go-up   go-down


67. Sharma S, Kumar D, Vashistha A, Bihani U, Trehan M: Recurrent unicystic ameloblastoma of the infratemporal and temporal fossa. Int J Clin Pediatr Dent; 2009 Jan;2(1):33-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Recurrent unicystic ameloblastoma of the infratemporal and temporal fossa.
  • The ameloblastoma has been described as benign but locally invasive; benign and locally invasive with strong tendency to recur; and locally malignant.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 25206097.001).
  • [ISSN] 0974-7052
  • [Journal-full-title] International journal of clinical pediatric dentistry
  • [ISO-abbreviation] Int J Clin Pediatr Dent
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] India
  • [Other-IDs] NLM/ PMC4086554
  • [Keywords] NOTNLM ; Unicystic / ameloblastoma / infratemporal temporal.
  •  go-up   go-down


68. Adebiyi KE, Ugboko VI, Omoniyi-Esan GO, Ndukwe KC, Oginni FO: Clinicopathological analysis of histological variants of ameloblastoma in a suburban Nigerian population. Head Face Med; 2006;2:42
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathological analysis of histological variants of ameloblastoma in a suburban Nigerian population.
  • BACKGROUND: This study was carried out to establish the relative incidence and provide clinico-pathologic information on the various histological types of ameloblastoma seen at the Obafemi Awolowo University Teaching Hospital complex, Ile-Ife in order to provide a baseline data which will be of significance to the pathologist and clinician.
  • METHODS: Clinico-pathologic data on a total of 77 histologically diagnosed cases of ameloblastoma archieved at the Obafemi Awolowo University Teaching Hospital Complex, Ile-Ife over a 15 year period were obtained and analysed descriptively.
  • RESULTS: Follicular ameloblastoma was the most common histological type (50 cases, 64.9%), followed by plexiform ameloblastoma (10 cases, 13.0%).
  • 4 (5.2%) cases of desmoplastic and 3 (3.9%) cases of acanthomatous ameloblastoma were seen while the basal cell variant accounted for 2 (2.6%) cases.
  • Ameloblastoma occurred over an age range of 11 to 70 years with a peak age incidence in the 3rd decade.
  • CONCLUSION: This study provides a baseline data on variants of ameloblastoma as obtained in a suburban Nigerian population.
  • Since variants of ameloblastoma differ in biologic behaviour, the data collected in this study provides clinicopathologic information which is of significance to the pathologist and clinician.
  • [MeSH-major] Ameloblastoma / pathology. Jaw Neoplasms / pathology. Suburban Population

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Surg Oral Med Oral Pathol. 1967 Sep;24(3):392-403 [5233386.001]
  • [Cites] West Afr Med J Niger Pract. 1968 Apr;17(2):45-9 [5655728.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1975 Oct;40(4):502-21 [1058441.001]
  • [Cites] J Oral Surg. 1978 Oct;36(10):771-8 [280645.001]
  • [Cites] Int J Oral Surg. 1981 Aug;10(4):255-60 [6809655.001]
  • [Cites] J Oral Maxillofac Surg. 1985 Sep;43(9):707-17 [3861827.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1987 Jan;63(1):78-84 [3468468.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1987 Apr;63(4):441-51 [3472145.001]
  • [Cites] Aust Dent J. 1990 Dec;35(6):518-22 [2090083.001]
  • [Cites] Dent Update. 1991 Sep;18(7):309-12 [1810789.001]
  • [Cites] Eur J Cancer B Oral Oncol. 1993 Jul;29B(3):169-71 [8298419.001]
  • [Cites] J Oral Pathol Med. 1995 Nov;24(10):454-7 [8600281.001]
  • [Cites] Int J Oral Maxillofac Surg. 2004 Dec;33(8):766-70 [15556324.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Feb;99(2):191-5 [15660091.001]
  • [Cites] Quintessence Int. 2006 Jan;37(1):69-74 [16429706.001]
  • [Cites] Acta Cytol. 2000 Jan-Feb;44(1):81-5 [10667166.001]
  • [Cites] Oral Surg Oral Med Oral Pathol. 1987 Jun;63(6):688-97 [3295656.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Jun;91(6):649-53 [11402276.001]
  • [Cites] Pesqui Odontol Bras. 2001 Oct-Dec;15(4):308-13 [11787319.001]
  • [Cites] Am J Surg Pathol. 2000 Oct;24(10):1385-92 [11023100.001]
  • [Cites] J Oral Maxillofac Surg. 2003 Sep;61(9):1004-10 [12966474.001]
  • [Cites] J Oral Pathol Med. 2002 Aug;31(7):415-20 [12165060.001]
  • (PMID = 17125498.001).
  • [ISSN] 1746-160X
  • [Journal-full-title] Head & face medicine
  • [ISO-abbreviation] Head Face Med
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  • [Other-IDs] NLM/ PMC1675998
  • [General-notes] NLM/ Original DateCompleted: 20070724
  •  go-up   go-down


69. Barber AJ, Hanlon R, Rogers SN: Skull base osteomyelitis after maxillectomy: a rare complication. Br J Oral Maxillofac Surg; 2009 Jun;47(4):310-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We report a case of skull base osteomyelitis that presented 4-8 weeks after a level 2 maxillectomy for a plexiform ameloblastoma of the right posterior maxilla.
  • [MeSH-major] Ameloblastoma / complications. Maxillary Neoplasms / complications. Osteomyelitis / etiology

  • Genetic Alliance. consumer health - Osteomyelitis.
  • Hazardous Substances Data Bank. CIPROFLOXACIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19243868.001).
  • [ISSN] 1532-1940
  • [Journal-full-title] The British journal of oral & maxillofacial surgery
  • [ISO-abbreviation] Br J Oral Maxillofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Scotland
  • [Chemical-registry-number] 5E8K9I0O4U / Ciprofloxacin
  •  go-up   go-down


70. Ulmar B, Delling G, Werner M, Huch K, Reichel H: Classical and atypical location of adamantinomas--presentation of two cases. Onkologie; 2006 Jun;29(6):276-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The diagnostic work-up including biopsy verified an adamantinoma in both cases.
  • In the younger patient, the tumor was located in the metatarsals 4 and 5, in the older patient in the left tibial diaphyses.
  • In both patients, an en-bloc resection of the tumor with wide surgical margins was performed.
  • [MeSH-major] Adamantinoma / diagnosis. Adamantinoma / surgery. Bone Neoplasms / diagnosis. Bone Neoplasms / surgery. Metatarsal Bones / surgery. Tibia / surgery

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16783903.001).
  • [ISSN] 0378-584X
  • [Journal-full-title] Onkologie
  • [ISO-abbreviation] Onkologie
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Switzerland
  •  go-up   go-down


71. da Silva TA, Batista AC, Mendonça EF, Leles CR, Fukada S, Cunha FQ: Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Mar;105(3):333-41
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparative expression of RANK, RANKL, and OPG in keratocystic odontogenic tumors, ameloblastomas, and dentigerous cysts.
  • STUDY DESIGN: The expression of these molecules was evaluated in solid/multicystic ameloblastomas (n = 12) and unicystic ameloblastomas (n = 8), keratocystic odontogenic tumors (n = 19), dentigerous cysts (n = 9), and dental follicles (n = 9) by immunohistochemistry.
  • With regard to stroma, the number of RANK-positive and RANKL-positive cells was higher in solid/multicystic ameloblastomas compared with dentigerous cysts.
  • Dental follicles had lower numbers of RANK-positive, RANKL-positive, and OPG-positive cells than solid/multicystic ameloblastomas and keratocystic odontogenic tumors.
  • The majority of solid/multicystic ameloblastomas (75%) and unicystic ameloblastomas (62.5%) had higher numbers of RANKL-positive than OPG-positive cells.
  • [MeSH-minor] Ameloblastoma / metabolism. Ameloblastoma / pathology. Cell Count. Epithelial Cells / metabolism. Gene Expression. Humans. Osteolysis / pathology. Root Resorption / pathology. Statistics, Nonparametric. Stromal Cells / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18061491.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / NF-kappa B; 0 / Osteoprotegerin; 0 / RANK Ligand
  •  go-up   go-down


72. Oral pathology quiz. Case number 3. Ameloblastoma. J N J Dent Assoc; 2010;81(1):15, 19
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oral pathology quiz. Case number 3. Ameloblastoma.
  • [MeSH-major] Ameloblastoma / radiography. Mandibular Neoplasms / radiography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20458795.001).
  • [ISSN] 0093-7347
  • [Journal-full-title] Journal of the New Jersey Dental Association
  • [ISO-abbreviation] J N J Dent Assoc
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


73. Bayi el H, El Harti K, Chbicheb S, El Wady W, Oujilal A, Kzadri M: [Odontogenic myxoma of the maxillary]. Rev Stomatol Chir Maxillofac; 2006 Nov;107(5):389-92
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • INTRODUCTION: Odontogenic myxoma is a rare benign tumor that arises from the mesenchymal portion of the tooth germ.
  • It has a va-riable non-specific clinical and radiological appearance, and may be confused with other lesions such as ameloblastoma.
  • This tumor is locally aggressive, inducing important facial deformation and tooth displacement.

  • Genetic Alliance. consumer health - Odontogenic myxoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17128194.001).
  • [ISSN] 0035-1768
  • [Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale
  • [ISO-abbreviation] Rev Stomatol Chir Maxillofac
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


74. Kelly JM, Belding BA, Schaefer AK: Acanthomatous ameloblastoma in dogs treated with intralesional bleomycin. Vet Comp Oncol; 2010 Jun;8(2):81-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Acanthomatous ameloblastoma in dogs treated with intralesional bleomycin.
  • Acanthomatous ameloblastoma (AA) is a benign gingival tumour that often invades bone.
  • [MeSH-major] Ameloblastoma / veterinary. Antibiotics, Antineoplastic / therapeutic use. Bleomycin / therapeutic use. Dog Diseases / drug therapy. Gingival Neoplasms / veterinary

  • Hazardous Substances Data Bank. BLEOMYCIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20579320.001).
  • [ISSN] 1476-5829
  • [Journal-full-title] Veterinary and comparative oncology
  • [ISO-abbreviation] Vet Comp Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antibiotics, Antineoplastic; 11056-06-7 / Bleomycin
  •  go-up   go-down


76. Kawabata T, Takahashi K, Sugai M, Murashima-Suginami A, Ando S, Shimizu A, Kosugi S, Sato T, Nishida M, Murakami K, Iizuka T: Polymorphisms in PTCH1 affect the risk of ameloblastoma. J Dent Res; 2005 Sep;84(9):812-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Polymorphisms in PTCH1 affect the risk of ameloblastoma.
  • Ameloblastoma is the most common odontogenic tumor, but the genetic nature of the changes in the tumor cells has been unclear.
  • Both CTNNB1 and PTCH1 are important in tooth development and are expressed in ameloblastoma.
  • The aim of this study was to investigate whether genetic alterations of CTNNB1 and PTCH1 are present in ameloblastoma.
  • We investigated 14 cases of ameloblastoma.
  • The polymorphisms found in the ameloblastoma patients were further examined in a subsequent case-control study.
  • We found a CTNNB1 mutation in one case of plexiform-type ameloblastoma.
  • The proportion of CGG8 alleles was significantly higher in the ameloblastoma group.
  • The results of this study indicate a possible relationship between the CGG8 allele in PTCH1 and the risk for ameloblastoma.
  • [MeSH-major] Ameloblastoma / genetics. Receptors, Cell Surface / genetics

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16109989.001).
  • [ISSN] 0022-0345
  • [Journal-full-title] Journal of dental research
  • [ISO-abbreviation] J. Dent. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CTNNB1 protein, human; 0 / Cytoskeletal Proteins; 0 / PTCH protein, human; 0 / Patched Receptors; 0 / Patched-1 Receptor; 0 / Receptors, Cell Surface; 0 / Trans-Activators; 0 / beta Catenin
  •  go-up   go-down


77. Tincani AJ, Del Negro A, Araújo PP, Akashi HK, Neves Fda S, Martins AS: Head and neck reconstruction using infrahyoid myocutaneous flaps. Sao Paulo Med J; 2006 Sep 7;124(5):271-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Thirteen patients (92.8%) had squamous cell carcinoma (SCC) and one (7.2%) ameloblastoma.
  • The disease stage was T3 in eight (61.5%) of the SCC cases and T4 in five (38.5%).


78. Dao TV, Bastidas JA, Kelsch R, Kraut RA: Malignant ameloblastoma: a case report of a recent onset of neck swelling in a patient with a previously treated ameloblastoma. J Oral Maxillofac Surg; 2009 Dec;67(12):2685-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Malignant ameloblastoma: a case report of a recent onset of neck swelling in a patient with a previously treated ameloblastoma.
  • [MeSH-major] Ameloblastoma / diagnosis. Mandibular Neoplasms / diagnosis. Submandibular Gland Diseases / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19925992.001).
  • [ISSN] 1531-5053
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


79. Hsieh HP, Cheng PW, Tsai CC: Radiology quiz case 4. A large unicystic ameloblastoma of mandible. Arch Otolaryngol Head Neck Surg; 2005 Jan;131(1):76; diagnosis 79-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Radiology quiz case 4. A large unicystic ameloblastoma of mandible.
  • [MeSH-major] Ameloblastoma / diagnosis. Mandibular Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15655196.001).
  • [ISSN] 0886-4470
  • [Journal-full-title] Archives of otolaryngology--head & neck surgery
  • [ISO-abbreviation] Arch. Otolaryngol. Head Neck Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


80. Hall JM, Weathers DR, Unni KK: Ameloblastic carcinoma: an analysis of 14 cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Jun;103(6):799-807
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: To present the classifications of malignant ameloblastomas, provide histopathologic guidelines for the diagnosis of ameloblastic carcinoma, and discuss treatment and long-term follow-up.
  • The patients with the highest number of recurrences did not survive the disease.

  • Genetic Alliance. consumer health - Ameloblastic carcinoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17448710.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


81. Nakano K, Siar CH, Tsujigiwa H, Nagatsuka H, Nagai N, Kawakami T: Notch signaling in benign and malignant ameloblastic neoplasms. Eur J Med Res; 2008 Oct 27;13(10):476-80
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: In general, Notch is a representative signal which controls morphosis and differentiation of cells, but its role in human odontogenic neoplasms, especially in ameloblastoma and its malignant counterpart, ameloblastic carcinoma, is not known.
  • METHODS: We examined Notch1 peptide and its gene (mRNA) in an ameloblastoma (case 1: 27-year-old female, right mandibular tumor) and an ameloblastic carcinoma (case 2: 93-year-old female, right mandibular tumor), using immunohistochemistry (IHC) and in situ hybridization (ISH) techniques.
  • RESULTS: Notch1 intracellular domain (NICD) positive products were observed in the cells at the peripheral layer of most proliferating epithelial tumor nests in case 1.
  • CONCLUSIONS: Notch signaling plays some role in cytological differentiation or acquisition of tissue specific characteristics in neoplastic cells of odontogenic neoplasms, including ameloblastoma and ameloblastic carcinoma.
  • [MeSH-major] Ameloblastoma / genetics. Ameloblastoma / metabolism. Mandibular Neoplasms / genetics. Mandibular Neoplasms / metabolism. Receptor, Notch1 / genetics. Receptor, Notch1 / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19008176.001).
  • [ISSN] 0949-2321
  • [Journal-full-title] European journal of medical research
  • [ISO-abbreviation] Eur. J. Med. Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / NOTCH1 protein, human; 0 / RNA, Messenger; 0 / RNA, Neoplasm; 0 / Receptor, Notch1
  •  go-up   go-down


82. Dimba EA, Gichana J, Limo AK, Wakoli KA, Chindia ML, Awange DO: An audit of oral diseases at a Nairobi centre, 2000-2004. Int Dent J; 2007 Dec;57(6):439-44
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The most common benign tumour was the ameloblastoma (50.23%: n = 109), which predominantly affected the mandible, and also occurred in male patients at a younger age (p = 0.023).
  • Peak incidences for malignant disease were observed in the sixth decade (mean age +/- SD = 46.94 +/- 18.99 years).
  • [MeSH-minor] Adolescent. Adult. Age Distribution. Aged. Aged, 80 and over. Ameloblastoma / epidemiology. Carcinoma, Squamous Cell / epidemiology. Child. Child, Preschool. Cysts / epidemiology. Female. Humans. Hyperplasia / epidemiology. Incidence. Infant. Infant, Newborn. Kenya / epidemiology. Male. Middle Aged. Mouth Neoplasms / epidemiology. Retrospective Studies. Sex Distribution

  • MedlinePlus Health Information. consumer health - Mouth Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18265777.001).
  • [ISSN] 0020-6539
  • [Journal-full-title] International dental journal
  • [ISO-abbreviation] Int Dent J
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] England
  •  go-up   go-down


83. Kumamoto H, Ooya K: Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors. J Oral Pathol Med; 2006 Nov;35(10):606-12
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Tissue specimens of 11 tooth germs, 44 ameloblastomas, and five malignant ameloblastic tumors were examined immunohistochemically with the use of antibodies against PD-ECGF/TP and angiopoietin-1 and -2.
  • RESULTS: Immunohistochemical reactivity for PD-ECGF/TP was detected in mesenchymal cells in tooth germs and stromal cells in ameloblastic tumors, and the level of immunoreactivity for PD-ECGF/TP was significantly higher in ameloblastomas than in tooth germs.
  • Granular cell ameloblastomas showed PD-ECGF/TP reactivity in granular neoplastic cells as well as in stromal cells.
  • Malignant ameloblastic tumors had decreased angiopoietin-1 reactivity and ameloblastic carcinomas had increased angiopoietin-2 reactivity as compared with the respective levels in tooth germs and ameloblastomas.
  • Immunohistochemical reactivity for angiopoietin-2 was slightly higher in follicular ameloblastomas than in plexiform ameloblastomas.
  • CONCLUSION: Expression of PD-ECGF/TP and angiopoietin-1 and -2 in tooth germs and ameloblastic tumors suggests that these angiogenic factors participate in tooth development and odontogenic tumor progression by regulating angiogenesis.
  • Altered expression of PD-ECGF/TP and angiopoietins in ameloblastic tumors may be involved in oncogenesis, malignant potential, and tumor cell differentiation.
  • [MeSH-major] Ameloblastoma / chemistry. Angiopoietin-1 / analysis. Angiopoietin-2 / analysis. Jaw Neoplasms / chemistry. Thymidine Phosphorylase / analysis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17032393.001).
  • [ISSN] 0904-2512
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / ANGPT1 protein, human; 0 / Angiopoietin-1; 0 / Angiopoietin-2; EC 2.4.2.4 / Thymidine Phosphorylase
  •  go-up   go-down


84. Tyndorf MM, Manowska B, Arkuszewski P: [Usefulness of classic radiographs in the preliminary evaluation of mandibular radiolucencies]. Wiad Lek; 2008;61(10-12):258-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Usually they are benign lesions such as odontogenic cyst or periapical granulomas but very similar radiological morphology may deal with aggressive tumors such as ameloblastoma, myxoma or calcifying epidermoid odontogenic tumor (CEOT).
  • CEOT, ameloblastoma or fibroma osyficans. CONCLUSIONS:.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19323065.001).
  • [ISSN] 0043-5147
  • [Journal-full-title] Wiadomości lekarskie (Warsaw, Poland : 1960)
  • [ISO-abbreviation] Wiad. Lek.
  • [Language] pol
  • [Publication-type] English Abstract; Evaluation Studies; Journal Article
  • [Publication-country] Poland
  •  go-up   go-down


85. Yamanishi T, Ando S, Aikawa T, Kishino M, Nakano Y, Sasai K, Isomura Tanaka E, Tsuji T, Koizumi H, Iida S, Kogo M: A case of extragingival peripheral ameloblastoma in the buccal mucosa. J Oral Pathol Med; 2007 Mar;36(3):184-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A case of extragingival peripheral ameloblastoma in the buccal mucosa.
  • Peripheral ameloblastomas (PAs) of the extragingival areas are extremely rare.
  • The tumor was surgically removed by blunt dissection and there is no evidence of recurrence for 7 months.
  • We also discuss here the clinical characteristics, the origin, and the management of the tumor by reference to the relevant literature.
  • [MeSH-major] Ameloblastoma / pathology. Mouth Mucosa / pathology. Mouth Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17305641.001).
  • [ISSN] 0904-2512
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Denmark
  •  go-up   go-down


86. Bologna-Molina R, Mosqueda-Taylor A, de Almeida-Oslei P, Toral-Rizo V, Martínez-Mata G: Peripheral desmoplastic ameloblastoma: histopathological and immunohistochemical profile of a case. Med Oral Patol Oral Cir Bucal; 2010 Nov;15(6):e846-9
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral desmoplastic ameloblastoma: histopathological and immunohistochemical profile of a case.
  • In this study we present a rare case of peripheral desmoplastic ameloblastoma and discuss its clinical features, histopathology, and immunohistochemical profile.
  • Histopathological findings were similar to the two previously reported cases of this tumor.
  • Reports of new cases of peripheral desmoplastic ameloblastoma are necessary for a better understanding of the origin and behavior of this particular subtype of ameloblastoma.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20526273.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


87. Flowers R, Baliga M, Guo M, Liu SS: Tibial adamantinoma with local recurrence and pulmonary metastasis: report of a case with histocytologic findings. Acta Cytol; 2006 Sep-Oct;50(5):567-73
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Tibial adamantinoma with local recurrence and pulmonary metastasis: report of a case with histocytologic findings.
  • BACKGROUND: Adamantinoma is a rare primary bone neoplasm of low malignant potential that may recur or metastasize in a mall percentage of patients.
  • The myriad histologic patterns may cause difficulty in distinguishing this tumor from other primary or metastatic neoplasms.
  • CASE: A 32-year-old man presented with a mass in the distal side of the left leg that was diagnosed as classic adamantinoma by open biopsy.
  • CONCLUSION: The diagnosis of adamantinoma requires knowledge of compatible clinical and radiologic studies as well as understanding of the variable histologic patterns that one may encounter.
  • Fine needle aspiration biopsy is particularly useful in the diagnosis of recurrent and metastatic adamantinoma.
  • This case report describes a distinctive cytomorphologic feature of nuclear grooves that may be a useful aid in distinguishing the tumor cells of adamantinoma from other cell types.
  • [MeSH-major] Adamantinoma / diagnosis. Bone Neoplasms / diagnosis. Lung / pathology. Lung Neoplasms / diagnosis. Neoplasm Recurrence, Local / diagnosis. Tibia / pathology
  • [MeSH-minor] Adult. Amputation. Biomarkers, Tumor / analysis. Biomarkers, Tumor / biosynthesis. Biopsy, Fine-Needle. Cell Shape. Diagnosis, Differential. Disease Progression. Epithelial Cells / pathology. Humans. Magnetic Resonance Imaging. Male. Nuclear Envelope / pathology. Prognosis

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17017449.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


88. Torres-Lagares D, Infante-Cossío P, Hernández-Guisado JM, Gutiérrez-Pérez JL: Mandibular ameloblastoma. A review of the literature and presentation of six cases. Med Oral Patol Oral Cir Bucal; 2005 May-Jul;10(3):231-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mandibular ameloblastoma. A review of the literature and presentation of six cases.
  • Ameloblastoma is a benign odontogenic tumour of epithelial origin without induction in the connective tissue.
  • Articles have recently been published with the purpose of providing updated knowledge and therapeutic approaches to ameloblastoma.
  • We present six cases of patients with localised mandibular ameloblastoma who were treated during the last seven years.
  • We present data on clinical appearance, histological characteristics, and therapeutic approach that was used, which included excision of the lesion, perilesional drilling of the bone, or block resection, according to the type of ameloblastoma.
  • The aim of this paper is to review the concepts relating to ameloblastoma that have been published recently and to assess their influence on the clinical attitude taken when facing this pathology, using our experience with ameloblastoma as a starting point to illustrate this discussion.
  • [MeSH-major] Ameloblastoma / pathology. Mandibular Neoplasms / pathology

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15876966.001).
  • [ISSN] 1698-6946
  • [Journal-full-title] Medicina oral, patología oral y cirugía bucal
  • [ISO-abbreviation] Med Oral Patol Oral Cir Bucal
  • [Language] eng; spa
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Spain
  • [Number-of-references] 33
  •  go-up   go-down


89. Cardoso A, Lazow SK, Solomon MP, Berger JR, Rock A: Metastatic ameloblastoma to the cervical lymph nodes: a case report and review of literature. J Oral Maxillofac Surg; 2009 Jun;67(6):1163-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Metastatic ameloblastoma to the cervical lymph nodes: a case report and review of literature.
  • [MeSH-major] Ameloblastoma / secondary. Lymphatic Metastasis / pathology. Mandibular Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19446199.001).
  • [ISSN] 1531-5053
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 20
  •  go-up   go-down


90. Khanna M, Delaney D, Tirabosco R, Saifuddin A: Osteofibrous dysplasia, osteofibrous dysplasia-like adamantinoma and adamantinoma: correlation of radiological imaging features with surgical histology and assessment of the use of radiology in contributing to needle biopsy diagnosis. Skeletal Radiol; 2008 Dec;37(12):1077-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Osteofibrous dysplasia, osteofibrous dysplasia-like adamantinoma and adamantinoma: correlation of radiological imaging features with surgical histology and assessment of the use of radiology in contributing to needle biopsy diagnosis.
  • OBJECTIVES: The aim of this study was to correlate the imaging features with surgical histology for tibial osteofibrous dysplasia (OFD), osteofibrous dysplasia-like adamantinoma (OFD/LA) and classical adamantinoma and to determine the additional role of imaging in suggesting a correct diagnosis in cases of needle biopsy misdiagnosis.
  • RESULTS: The 24 cases comprised five OFD, 11 OFD/LA and eight adamantinoma based on surgical resection histology.
  • The mean length of OFD was 6.1 cm (range 2-8.5 cm), for OFD/LA was 6.5 cm (range 2-13 cm) and for adamantinoma was 13.2 cm (range 6.5-26 cm).
  • Four of 19 cases had a different needle biopsy result compared to the final histology, three cases being upgraded from an OFD/LA or OFD to classical adamantinoma.
  • The radiological features of these three cases were more in keeping with a diagnosis of adamantinoma.
  • CONCLUSIONS: A diagnosis of classical adamantinoma is suggested by an extensive lesion with moth-eaten margins and complete involvement of the medullary cavity on axial MR imaging.
  • [MeSH-major] Adamantinoma / diagnosis. Adamantinoma / surgery. Fibrous Dysplasia of Bone / diagnosis. Fibrous Dysplasia of Bone / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Orthop Relat Res. 1992 May;(278):235-43 [1563159.001]
  • [Cites] Acta Clin Belg. 1990;45(1):31-3 [2161603.001]
  • [Cites] J Bone Joint Surg Am. 2000 Aug;82-A(8):1122-31 [10954102.001]
  • [Cites] Arch Pediatr Adolesc Med. 1997 Apr;151(4):427-8 [9111446.001]
  • [Cites] AJR Am J Roentgenol. 1991 May;156(5):1017-23 [2017924.001]
  • [Cites] Hum Pathol. 1993 Dec;24(12 ):1339-47 [8276381.001]
  • [Cites] Rofo. 1992 Sep;157(3):239-44 [1391818.001]
  • [Cites] Cancer. 1989 Aug 1;64(3):730-7 [2743266.001]
  • [Cites] J Bone Joint Surg Am. 1981 Mar;63(3):367-75 [7204433.001]
  • [Cites] J Bone Joint Surg Br. 2006 May;88(5):658-64 [16645116.001]
  • [Cites] AJR Am J Roentgenol. 2004 Dec;183(6):1737-44 [15547221.001]
  • [Cites] Skeletal Radiol. 2003 May;32(5):245-58 [12679847.001]
  • [Cites] J Bone Joint Surg Am. 1994 Oct;76(10):1482-99 [7929496.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):215-37 [3514033.001]
  • (PMID = 18690429.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


91. Scheper MA, Chaisuparat R, Nikitakis NG, Sauk JJ: Expression and alterations of the PTEN / AKT / mTOR pathway in ameloblastomas. Oral Dis; 2008 Sep;14(6):561-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression and alterations of the PTEN / AKT / mTOR pathway in ameloblastomas.
  • OBJECTIVES: Recently, an allelic loss of phosphatase and tensin homologue (PTEN) was shown to occur in ameloblastomas.
  • METHODS: Thirty ameloblastomas and five dental follicles were studied, looking at the immunohistochemical expression of total PTEN and AKT, as well as their phosphorylated (p) active forms, and the downstream effector and indicator of mTOR activity p70 ribosomal-subunit-6 kinase (pS6K).
  • RESULTS: Total PTEN was absent in 33.3% of ameloblastomas, while its stabilized, phosphorylated(ser380 / thr382 / thr383) form was absent in 83.3% of tumors.
  • In contrast, AKT was expressed in 83.3% of ameloblastomas, showing high expression of the p-thr(308)AKT and p-ser(473) AKT forms in 93.3% and 56.6% of cases, respectively.
  • Further, the mTOR activated pS6K(ser240 / 244) was detected in 86.7% of ameloblastomas, while ERK was overexpressed in 70.0% of the cases.
  • CONCLUSION: Immunohistochemical analysis of aberrant signaling in the PI3K/AKT/mTOR pathway in ameloblastomas may represent a valuable tool for elucidating pathogenesis, aggressiveness and selecting optimal therapeutics.
  • [MeSH-major] Ameloblastoma / pathology. PTEN Phosphohydrolase / analysis. Phosphatidylinositol 3-Kinases / analysis. Protein Kinases / analysis. Proto-Oncogene Proteins c-akt / analysis

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18826385.001).
  • [ISSN] 1601-0825
  • [Journal-full-title] Oral diseases
  • [ISO-abbreviation] Oral Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] EC 2.7.- / Protein Kinases; EC 2.7.1.- / Phosphatidylinositol 3-Kinases; EC 2.7.1.1 / MTOR protein, human; EC 2.7.1.1 / TOR Serine-Threonine Kinases; EC 2.7.11.1 / Proto-Oncogene Proteins c-akt; EC 2.7.11.1 / Ribosomal Protein S6 Kinases, 70-kDa; EC 2.7.11.1 / ribosomal protein S6 kinase, 70kD, polypeptide 2; EC 2.7.11.24 / Extracellular Signal-Regulated MAP Kinases; EC 3.1.3.48 / PTEN protein, human; EC 3.1.3.67 / PTEN Phosphohydrolase
  •  go-up   go-down


92. Iezzi G, Piattelli A, Rubini C, Artese L, Goteri G, Fioroni M, Carinci F: CD10 expression in stromal cells of ameloblastoma variants. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Feb;105(2):206-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CD10 expression in stromal cells of ameloblastoma variants.
  • OBJECTIVE: We performed an immunohistochemical study in a series of ameloblastomas with different histology to explore the existence of a correlation between CD10 immunoreactivity in peritumoral stromal cells and the type of ameloblastoma with a high risk of local recurrence.
  • STUDY DESIGN: A total of 45 ameloblastomas (18 unicystic [UA], 4 peripheral [PA], 23 solid/multicystic [SA]) were evaluated.
  • CONCLUSIONS: Our results suggest that CD10 expression might be associated with stromal invasion in ameloblastoma variants with a high risk of recurrences.
  • [MeSH-major] Ameloblastoma / classification. Ameloblastoma / immunology. Jaw Neoplasms / classification. Jaw Neoplasms / immunology. Neprilysin / biosynthesis

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17942343.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] EC 3.4.24.11 / Neprilysin
  •  go-up   go-down


93. Sakellariou VI, Mavrogenis AF, Papagelopoulos PJ: Limb salvage surgery using the intramedullary diaphyseal segmental defect fixation system. J Long Term Eff Med Implants; 2008;18(1):59-67
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Histological diagnosis included adamantinoma, synovial sarcoma, multiple myeloma, metastatic renal cell carcinoma, myeloid carcinoma of the thyroid gland, and adenocarcinoma of the stomach.
  • At the latest examination, five patients were free of local or distant disease and one patient had deceased with distant disease, without evidence of local recurrence.

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19348612.001).
  • [ISSN] 1050-6934
  • [Journal-full-title] Journal of long-term effects of medical implants
  • [ISO-abbreviation] J Long Term Eff Med Implants
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


94. Kumamoto H, Ooya K: Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas. J Oral Pathol Med; 2005 May;34(5):287-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Expression of tumor necrosis factor alpha, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas.
  • BACKGROUND: To clarify the roles of the apoptosis signaling pathway mediated by death receptors in oncogenesis and cytodifferentiation of odontogenic tumors, expression of tumor necrosis factor alpha (TNFalpha), TNF-related apoptosis-inducing ligand (TRAIL), and their associated molecules was analyzed in ameloblastomas as well as in tooth germs.
  • METHODS: Tissue specimens of 10 tooth germs, 40 benign ameloblastomas, and five malignant ameloblastomas were examined by reverse transcriptase-polymerase chain reaction (RT-PCR) and immunohistochemistry to determine the expression of TNFalpha, TNF receptor I (TNFRI), TRAIL, TRAIL receptor 1 (TRAIL-R1), TRAIL-R2, caspase-8, and nuclear factor-kappaB (NF-kappaB).
  • Expression of caspase-8 mRNA was identified in six of 33 ameloblastomas, but not in 10 tooth germs or one malignant ameloblastoma.
  • Epithelial expression of TNFalpha was focal in about 50% of tooth germs and ameloblastomas, and TNFalpha expression in neoplastic cells was significantly higher in follicular ameloblastomas than in plexiform ameloblastomas.
  • Expression of caspase-8 was found in some neoplastic cells in three of 37 ameloblastomas, but not in 10 tooth germs or five malignant ameloblastomas.
  • CONCLUSION: Expression of TNFalpha, TRAIL, and their receptors in tooth germs and ameloblastomas suggests that these death factors might be involved in cytodifferentiation of odontogenic epithelium and tissue structuring of ameloblastomas.
  • [MeSH-major] Ameloblastoma / metabolism. Apoptosis. Jaw Neoplasms / metabolism. Membrane Glycoproteins / biosynthesis. Tumor Necrosis Factor-alpha / biosynthesis
  • [MeSH-minor] Apoptosis Regulatory Proteins. Caspase 8. Caspases / biosynthesis. Humans. Immunoenzyme Techniques. NF-kappa B / biosynthesis. RNA, Messenger / analysis. Receptors, TNF-Related Apoptosis-Inducing Ligand. Receptors, Tumor Necrosis Factor / biosynthesis. Reverse Transcriptase Polymerase Chain Reaction. Signal Transduction. Statistics, Nonparametric. TNF-Related Apoptosis-Inducing Ligand. Tooth Germ / metabolism. Tumor Necrosis Factor Receptor-Associated Peptides and Proteins / metabolism

  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15817072.001).
  • [ISSN] 0904-2512
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / Apoptosis Regulatory Proteins; 0 / Membrane Glycoproteins; 0 / NF-kappa B; 0 / RNA, Messenger; 0 / Receptors, TNF-Related Apoptosis-Inducing Ligand; 0 / Receptors, Tumor Necrosis Factor; 0 / TNF-Related Apoptosis-Inducing Ligand; 0 / TNFRSF10A protein, human; 0 / TNFRSF10B protein, human; 0 / TNFSF10 protein, human; 0 / Tumor Necrosis Factor Receptor-Associated Peptides and Proteins; 0 / Tumor Necrosis Factor-alpha; EC 3.4.22.- / CASP8 protein, human; EC 3.4.22.- / Caspase 8; EC 3.4.22.- / Caspases
  •  go-up   go-down


95. Zhong M, Liu JD, Wang J, Liu J, Li L, Hou L, Zhang B: [Expression and significance of hTERT, c-fos and c-jun in ameloblastoma]. Shanghai Kou Qiang Yi Xue; 2006 Oct;15(5):461-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Expression and significance of hTERT, c-fos and c-jun in ameloblastoma].
  • PURPOSE: To investigate the expression of c-fos, c-jun and hTERT mRNA in human ameloblastoma (AB) and to determine their clinicobiological significance.
  • METHODS: In situ hybridization was performed to examine the expression of c-fos, c-jun and hTERT mRNA in AB and 7 cases of normal oral mucosa (NOM), 16 cases of keratocystic odontogenic tumor (KCOT) were selected as controls.
  • [MeSH-major] Ameloblastoma / metabolism. Jaw Neoplasms / metabolism. RNA, Messenger / metabolism

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17348214.001).
  • [ISSN] 1006-7248
  • [Journal-full-title] Shanghai kou qiang yi xue = Shanghai journal of stomatology
  • [ISO-abbreviation] Shanghai Kou Qiang Yi Xue
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / RNA, Messenger
  •  go-up   go-down


96. Sandra F, Hendarmin L, Nakao Y, Nakamura N, Nakamura S: TRAIL cleaves caspase-8, -9 and -3 of AM-1 cells: a possible pathway for TRAIL to induce apoptosis in ameloblastoma. Tumour Biol; 2005 Sep-Oct;26(5):258-64
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] TRAIL cleaves caspase-8, -9 and -3 of AM-1 cells: a possible pathway for TRAIL to induce apoptosis in ameloblastoma.
  • Tumor-necrosis-factor-related apoptosis-inducing ligand (TRAIL/Apo-2L), a potent ligand in inducing apoptosis, has recently emerged as a novel anticancer agent based on its ability to induce apoptosis in tumor cells, while exhibiting no toxicity in most normal cells.
  • Since no potent apoptosis-inducing factor has been found yet in ameloblastoma, the present study was conducted.
  • In the present study, expressions of TRAIL receptors, death receptor 4 (DR4) and DR5, were detected in all ameloblastoma tissues by immunohistochemistry as well as in AM-1 cells by immunofluorescence.
  • By applying TRAIL in AM-1 cells, ameloblastoma cell line, for 24 h, we found that TRAIL cleaved caspase-8, -9 and -3, and lowered mitochondrial membrane potential (Deltapsim), and markedly induced apoptosis in AM-1 cells (46%).
  • These results suggested that TRAIL is a potent apoptosis-inducing ligand in ameloblastoma.
  • [MeSH-major] Apoptosis / genetics. Caspases / metabolism. Membrane Glycoproteins / physiology. Mouth Neoplasms / genetics. Mouth Neoplasms / physiopathology. Tumor Necrosis Factor-alpha / physiology

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2005 S. Karger AG, Basel.
  • (PMID = 16110259.001).
  • [ISSN] 1010-4283
  • [Journal-full-title] Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
  • [ISO-abbreviation] Tumour Biol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Apoptosis Regulatory Proteins; 0 / Ligands; 0 / Membrane Glycoproteins; 0 / TNF-Related Apoptosis-Inducing Ligand; 0 / TNFSF10 protein, human; 0 / Tumor Necrosis Factor-alpha; EC 3.4.22.- / CASP3 protein, human; EC 3.4.22.- / CASP8 protein, human; EC 3.4.22.- / CASP9 protein, human; EC 3.4.22.- / Caspase 3; EC 3.4.22.- / Caspase 8; EC 3.4.22.- / Caspase 9; EC 3.4.22.- / Caspases
  •  go-up   go-down


97. Kumamoto H, Ooya K: Immunohistochemical detection of MT1-MMP, RECK, and EMMPRIN in ameloblastic tumors. J Oral Pathol Med; 2006 Jul;35(6):345-51
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Tissue specimens of 11 tooth germs, 40 ameloblastomas, and five malignant ameloblastic tumors were examined immunohistochemically with the use of antibodies against MT1-MMP, RECK, and EMMPRIN.
  • RECK expression was lower in ameloblastomas than in tooth germs.
  • Follicular ameloblastomas showed significantly lower expression of RECK than plexiform ameloblastomas, and immunoreactivity for RECK in acanthomatous ameloblastomas was slightly lower than that in other cellular variants.
  • CONCLUSION: Expression of MT1-MMP, RECK and EMMPRIN in tooth germs and ameloblastic tumors suggests that these normal and neoplastic epithelial components control MMP-dependent extracellular matrix (ECM) degradation during tooth development and tumor progression via epithelial-mesenchymal interactions.
  • [MeSH-major] Ameloblastoma / chemistry. Antigens, CD147 / analysis. Jaw Neoplasms / chemistry. Matrix Metalloproteinases / analysis. Membrane Glycoproteins / analysis. Tooth Germ / chemistry

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16762015.001).
  • [ISSN] 0904-2512
  • [Journal-full-title] Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology
  • [ISO-abbreviation] J. Oral Pathol. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Denmark
  • [Chemical-registry-number] 0 / GPI-Linked Proteins; 0 / Membrane Glycoproteins; 0 / RECK protein, human; 136894-56-9 / Antigens, CD147; EC 3.4.24.- / Matrix Metalloproteinases; EC 3.4.24.- / Matrix Metalloproteinases, Membrane-Associated
  •  go-up   go-down


98. Ide F: Peripheral ameloblastoma of the buccal mucosa. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 May;109(5):653-4; author reply 654-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Peripheral ameloblastoma of the buccal mucosa.
  • [MeSH-major] Ameloblastoma / diagnosis. Cheek / pathology. Mouth Mucosa / pathology. Mouth Neoplasms / diagnosis

  • MedlinePlus Health Information. consumer health - Oral Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009 Oct;108(4):577-9 [19778743.001]
  • (PMID = 20416529.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Comment; Letter
  • [Publication-country] United States
  •  go-up   go-down


99. Tamme T, Tiigimäe J, Leibur E: Mandibular ameloblastoma: a 28-years retrospective study of the surgical treatment results. Minerva Stomatol; 2010 Nov-Dec;59(11-12):637-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mandibular ameloblastoma: a 28-years retrospective study of the surgical treatment results.
  • AIM: The aim of this study was to analyse the long-term treatment results of mandibular ameloblastomas over a 28-year period and determine the most appropriate method of management of these tumours.
  • METHODS: Sixteen patients with a diagnosis of mandibular ameloblastoma treated in our Department between January 1977 and December 2004 were selected for this retrospective study.
  • CONCLUSION: In summary, conservative treatment enucleation should be used only in the treatment of unicystic ameloblastoma, while the radical approach, resection with some safe margin, should be the first choice in the treatment of solid, multicystic mandibular ameloblastoma to avoid recurrence.
  • [MeSH-major] Ameloblastoma / surgery. Mandibular Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21217628.001).
  • [ISSN] 0026-4970
  • [Journal-full-title] Minerva stomatologica
  • [ISO-abbreviation] Minerva Stomatol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


100. Odukoya O, Effiom OA: Clinicopathological study of 100 Nigerian cases of ameloblastoma. Niger Postgrad Med J; 2008 Mar;15(1):1-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathological study of 100 Nigerian cases of ameloblastoma.
  • SUMMARY: Clinicopathological analysis and growth rate study of 100 cases of ameloblastoma was undertaken.
  • The estimated monthly growth rate (EMGR) of ameloblastoma was observed to be slower in males although the mean tumour volume recorded in females was lower than males in the series.
  • The biologic aggression of 4 various types of ameloblastoma was predicted using EMGR and average volume of tumour at hospital presentation as predictive markers.
  • Solid multicystic ameloblastoma was observed with the fastest EMGR of 0.81 cm(3)/month.
  • Peripheral ameloblastoma was observed with the slowest EMGR of 0.17 cm(3)/ month.
  • It was concluded that all the 4 types of ameloblastoma observed were clinically distinct and showed varying biologic aggression.
  • It is therefore necessary to distinguish between the various clinical types of ameloblastoma before a clinician proceeds with definitive treatment.
  • [MeSH-major] Ameloblastoma / pathology. Jaw Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18408774.001).
  • [ISSN] 1117-1936
  • [Journal-full-title] The Nigerian postgraduate medical journal
  • [ISO-abbreviation] Niger Postgrad Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nigeria
  •  go-up   go-down






Advertisement